Download 42. Honeymol John, Abdelrahman Nimeri, Samer Ellahham

CURRICULUM VITAE
PERSONAL INFORMATION
Name:
Samer Ellahham, MD,CPHQ,CMQ,EFQM,FACC,FAHA,FACP
Date of Birth:
August 16, 1961
Citizenship:
U. S.
Home Address:
Villa 17
Karama Area
Abu Dhabi, UAE
Home Phone:
02-447-5654
Personal Cellular Phone:
056-329-7853
Personal E - Mail:
[email protected]
UAE Business Addresses:
Sheikh Khalifa Medical City
Karama Street
Abu Dhabi,UAE
UAE Business Phone:
02-819-2070
UAE Business Cellular Phone:
050-811-3142
UAE Business E-Mail:
[email protected]
US Business Address:
Cleveland Clinic Foundation
International Operations
1950 Richmond Road
Lyndhurst, Ohio 44124
US Phone Number:
216-448-8250
US E-mail address:
[email protected]
1
EDUCATION
1979 - 1982
AMERICAN UNIVERSITY OF BEIRUT
Beirut, Lebanon
B. S. in Biology
1982 - 1986
AMERICAN UNIVERSITY OF BEIRUT
SCHOOL OF MEDICINE
Beirut, Lebanon
M. D. Degree
1986 - 1987
INTERNSHIP
Internal Medicine
Good Samaritan Hospital
An Affiliate of Johns Hopkins Hospital
Baltimore, Maryland
1987 - 1988
RESIDENCY
Internal Medicine
Good Samaritan Hospital
An Affiliate of Johns Hopkins Hospital
Baltimore, Maryland
1988 - 1989
RESIDENCY
Internal Medicine
Washington Hospital Center
Washington, D. C.
1989 - 1992
FELLOWSHIP
Division of Cardiology
Medical College of Virginia
Richmond, Virginia
1991 - 1992
FELLOWSHIP
Division of Heart Failure
Medical College of Virginia
Richmond, Virginia
1991 - 1992
FELLOWSHIP
Division of Nuclear Cardiology
Medical College of Virginia
Richmond, Virginia
2
EDUCATION
1991 - 1992
RESEARCH FELLOWSHIP
Division of Cardiology
Medical College of Virginia
Richmond, Virginia
1991 - 1992
CLINICAL INSTRUCTOR
Cardiology Division
Medical College of Virginia
Richmond, Virginia
1989 - 1992
MEDICAL HOUSE PHYSICIAN
Johnston Willis Hospital
Henrico Doctors' Hospital
Richmond, Virginia
PROFESSIONAL AND TEACHING EXPERIENCE
1992 - 1993
ASSISTANT PROFESSOR
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, Virginia
1992-1993
DIRECTOR, CORONARY CARE UNIT
Hampton Veterans Affairs Medical Center
Hampton, Virginia
1993 –1994
DIRECTOR, DIAGNOSTIC EXERCISE
LABORATORY
Washington Heart
Washington Hospital Center
Washington, D.C.
1994 –2001
DIRECTOR, EXERCISE & PHARMACOLOGICAL
STRESS TESTING IMAGING LABORATOR
Washington Heart
Washington Hospital Center
Washington, D.C.
1997 – 2001
DIRECTOR, VASCULAR BIOLOGY LABORATORY
Washington Heart
Washington Hospital Center
Washington, D.C.
3
PROFESSIONAL AND TEACHING EXPERIENCE
1998- 2003
MEDICAL DIRECTOR, CARDIAC REHABILITATION
National Rehabilitation Hospital
Washington, D.C.
2001- 2003
DIRECTOR, CARDIOVASCULAR RESEARCH
Cardiothoracic Institute
George Washington University Medical Center
Washington, D.C.
2002- 2008
TEACHING ATTENDING
Georgetown University Medical Center
VHC/ Fairfax Hospital Campus
Washington, D.C.
2001- Present
DIRECTOR, PARAGON CARDIOVASCULAR
FOUNDATION
Falls Church, Virginia
2006- 2007
MEDICAL DIRECTOR, INNOVATIVE MEDICAL
INSTITUTE
Washington, D.C.
2008- Present
SENIOR CARDIOVASCULAR CONSULTANT
SKMC Managed by The Cleveland Clinic Foundation
Abu Dhabi, UAE
2009- Present
CHIEF QUALITY OFFICER
SKMC Managed by The Cleveland Clinic Foundation
AbuDhabi, UAE
2009- Present
CLEVELAND CLINIC UAE EXECUTIVE TEAM
SKMC Managed by The Cleveland Clinic Foundation
AbuDhabi, UAE
POST GRADUATE EDUCATION
Master of Public Health (MPH) Program
Part-time Professional Program
The Johns Hopkins University School of
Hygiene and Public Health
Baltimore, Maryland
4
CERTIFICATION
1987
ECFMG Certification: Valid indefinitely
1987
Maryland State Licence
1990
Diplomat of the American Board of Internal Medicine
1991
Advanced Cardiac Life Support (ACLS), Medical Director
1992
American Heart Association (AHA), Affiliate Faculty
1992
Nuclear Cardiology License
1993
Diplomat of the American Board of Internal Medicine
1994
Diplomat of the American Board of Cardiovascular Diseases
2005
Diplomat of the American Board of Cardiovascular Diseases,
Recertification
2007
SCCT CT Coronary Angiography Level I and II Certificate
2007
VNUS Certified in Total Vein Care
2007
SCCT CT Coronary Angiography Level III Certificate
2007
Vascular Imaging Certificate
2007
Diplomat, Vascular Medicine Board
2008
BLS
2008
ACLS
2010
Route Cause Analysis, Incident Mangement and Investigation
2010
Incident Reporting and Management
2012
Lean Six Sigma- Green Belt
2012
EFQM: Assessor 2013 Model
2013
Lean Certified in Healthcare
2013
Six Sigma - Black Belt
2014
ACLS Provider
2014
ACLS Instructor
5
CERTIFICATION
2015
National Institute of Health Research Certification
2015
Certified Professional in Healthcare Quality (CPHQ) by The
National Association for Healthcare Quality (NAHQ)
2015
Certified in Medical Quality (CMQ) by The American Board of
Medical Quality (ABMQ)
MEDICAL LICENSURE
Licensed to practice medicine in Virginia, USA and Abu Dhabi, UAE.
PROFESSIONAL AFFILIATIONS






























American Society of Nuclear Cardiology, Founding Member
American College of Cardiology, Fellow
American College of Physicians, Fellow
American College of Chest Physicians, Fellow
American Heart Association, Fellow
American Society of Quality, Full Member
American Medical Informatics Association, Member
American Medical Association, Member
American Diabetes Association, Member
Apollo, Member
International Society of Heart & Lung Transplantation, Member
Jacobs Institute of Women's Health, Member
Friends of American Medical Women Association (FAMWA)
The American Society of Hypertension, Specialist in Hypertension
Medical Society of District of Columbia, Member
Heart Failure Society of America, Member
Children’s Heart Link, Member
Vascular Biology Working Group, Member
Transcatheter Cardiovascular Therapeutics, Member
Society of Chest Pain Centers, Member
ACCP Sleep Medicine, Member
NAAMA, Member
Spirit of Women, Member
Thrombosis Clinic, Member
Pulmonary Vascular Disease Network, Member
The National Coalition for Women with Heart Disease
Society of Vascular Medicine , Member
American Society of Echocardiography, Member
The Erythromelalgia Association, Member
The Fibromuscular Dysplasia Society of America, Member
6

PROFESSIONAL AFFILIATIONS













Lymphatic Research Foundation, Member
The National Alliance for Thrombosis and Thrombophilia, Member
The Adult Congenital Heart Association, Member
Association for Professionals in Infection Control and Epidemiology, Member
American Society For Quality, Full Member
Agency for Healthcare Research and Quality, Member
National Association for Healthcare Quality, Member
Institute of Healthcare Improvement, Member
Institute of Healthcare Improvement, Passport Member
American Society of Quality, Member
American Society of Medical Quality, Member
National Association for Healthcare Quality, Member
American College of Medical Quality, Member
HONORS AND AWARDS
1979
Dean's Honor List
1981
Dean's Honor List
1982
Dean's Honor List
1984
Honors in Internal Medicine, Surgery and Psychiatry
1985
Honors in Internal Medicine and Pediatrics
1992
Medical College of Virginia Fellow of the Year,
Finalist
1992
DuPont Pharmaceuticals Research Award, ACCP
58th Annual Scientific Assembly, Young
Investigator Award
1992
Alfred Soffer Research Award, ACCP 58th Annual
Scientific Assembly, Finalist
1994
American College of Chest Physicians, Fellow
1996
President, AAMA, Washington, D.C. Chapter
1996
International Who's WHO of Professionals, Member
1997
American Heart Association Council on Clinical
Cardiology, Fellow
1997
American College of Physicians, Fellow
1998
Washington Hospital Center, Division
Cardiology, Teacher of The Year Award
of
7
HONORS AND AWARDS
1999
12th Annual Meeting of the Mediterranean
Association of Cardiology & Cardiac Surgery, First
Young Investigator Award
2000
Board Member, American Society of Hypertension,
Washington D.C. Chapter
2000
International Editorial Board Member, Hypertension Today
Journal
2000
International Editorial Board of the Focus on Hypertension
Journal
2001
Certificate of Appreciation, Department of US Army, Walter
Reed Medical Center
2001
Medical Director, Paragon Cardiovascular Foundation
2004
HSANV Board Member: VA STATE Elected Official Position
2005
American Board of Internal Medicine, Cardiovascular
Recertification
2006
International Editorial Board of the Focus On Hypertension
Journal
2006
Mid-Atlantic American Society of Hypertension Board of
Directors
2006
Reviewer of Pri-Med Institute, Cardiology Section
2006
Reviewer of Pri-Med Institute, Diabetes Section
2006
Medical Director – Innovative Medical Institute
2006
Dean Teaching Award, Georgetown University School of
Medicine
2006
AHA Get with the Guidelines (GAP) Award
2005
Society for Simulation in Healthcare
2007
Faculty Pri-Med Institute
2008
First GWTG Heart Failure Center outside the US
2009
Editorial Board - Open Access Journal of Clinical Trials
2011
President, International Association of Healthcare Quality
2011
Certificate of Appreciation, Certified Professional In Healthcare
Quality (CPHQ) Workshop
2011
SKMC, CEO Leadership Team Award
8
HONORS AND AWARDS
2011
Infection Prevention Day Award
Infection Prevention Is Everyone's Business
"In Recognition of your Support, Advocacy, & Influence for the
Success of Infection Prevention Program"
2011
Third Annual SEHA Research Conference
2012
National Surgical Quality Improvement Program
Executive Sponsor
2012
International Hand Hygiene Joint Commission Lean Sigma
Project: Executive Sponsor
2012
Lean Six Sigma-Green Belt
2012
Expert Reviewer of HACA Standard Reviewer: Cardiac Program
Certification Standards
2012
Joint Commission Center for Transforming Healthcare Award
2012
SKMC Infection Prevention Award: “In recognition of your
dedicated efforts in the International Hand Hygiene Pilot Project
for the Joint Commission Center for Transforming Healthcare as a
project sponsor with highest level leadership”
2012
Meirc Training Award
2012
Fifth Edition of JCI Standards: JCI Standards Advisory Panel
Member
2013
The United Arab Emirates Ministry of Health Patient Safety Award
2013
EFQM, Assessor 2013 Model
2013
Leader, SKMC SKEA Award Submission- Silver Award
2013
JCI Standard Advisory Panel Middle East Representative
2013
Lean Certified in Healthcare
2013
Six Sigma-Black Belt
2013
EFQM Risk Mangement Certified
2013
SEHA Transformational Event Diamond Award
2013
SEHA Finalist Clinical and Quality Hall of Fame
9
HONORS AND AWARDS
2014
ACLS Instructor
2014
Cleveland Clinic Executive Visitor’s Program
2014
Fellow, Gulf Heart Association
2014
Appreciation from Quality Division of UAE Minitry of Health
2014
Certificate of Recognition for valuable contribution to SEHA
Excellence Journey
2014
GCC Pharmaceutical Congress Dinstinguished Award
2014
Dubai Health Regulation Conference Award
2014
SKMC/CLEVELAND CLINIC Steering Committee/Board
Commendation for Exemplary Service
2015
SKMC Leader Dubai Quality Award Winner
2015
QUALITY LEADERSHIP AWARD from the World Quality
Congress and Awards
2015
BUSINESS LEADERSHIP EXCELLENCE AWARD from
World Leadership Congress
2015
Nominees for Safe Care magazine Person of the Year
2016
Clinical Transformation Event: Golden Award
2016
Operational Transformational Event: Golden Award
10
COMMITTEES

Chairman, Critical Care Equipment, Subcommittee, EVMS.

Member, Critical Care Committee, Hampton VA Medical Center.

Member, CCU Committee, Hampton VA Medical Center.

Member, Outcomes Initiative Committee, Washington Hospital Center.

Member, Washington Hospital Center Housestaff Recruitment Committee.

President and CEO - R & R Series Company, Inc.

Washington Heart Database Initiative, Member.

Washington Hospital Center Wellness Clinic, Member.

HSANV, Board Member.

Member, Data integrity Task Force, SKMC.

Member, Joint Service Review Committee (JSR), SKMC.

Member, Steering Committee, SKMC-SEHA.

Member, Research and Innovation Committee, SKMC.

Chairman, Search Committee for Chairman of Medicine, SKMC.

Chairman, Pressure Ulcer Prevention Team, SKMC.

Chairman, Accreditation and Compliance Committee, SKMC.

Chairman, JCI Executive Committee, SKMC.

Chairman, Quality Improvement and Patient Safety Committee, SKMC.

Chairman, International Patient Safety JCI Chapter, SKMC.

Chairman, Governance,Leadership and Direction JCI Chapter, SKMC.

Chairman, Quality and Patient Safety JCI Chapter, SKMC.

Chairman, Core-Measures/Clinical Starter Set Committee, SKMC.

Member, Senior Mangement Team, SKMC.

Member, Prevention and Control of Infection JCI Chapter, SKMC.

Member, Eduation JCI Chapter, SKMC.

Member, Research JCI Chapter, SKMC.

Member, Venous Thromboembolism Committee, SKMC.

Member, NSQIP Team, SKMC.

Member, Joint Service Review Team, SKMC.

Member, Peer-Review Committee, SKMC.

Member, Core Team, SKMC.

Member, Research and InnovationCommittee, SKMC.

Member City Governance, SKMC.
COMMITTEES
11

Member Strategic Committee, SKMC.

Member, Pain Management Committee, SKMC.

Member, Lenth of Stay Committee, SKMC.

Member, Health Promotion Committee, SKMC.

Member, Senior Management Council, SKMC.

Member, Infection Control Committee, SKMC.

Member, Medical Executive Council, SKMC.

Member, Chest Pain Accreditation, Steering Committee, SKMC.

Member, National Surgical Quality Improvement Team (NSQIP), SKMC.

Member, Health Information Committee, SKMC.

Member, Comprehensive Pain Mangement Committee, SKMC.

Member, BSP Operation Committee, SKMC.

Member, Data Integrity Task Force, SKMC.

Member, Operational Emergency Preparedness Committee, SKMC.

Member, Patient Experience Committee, SKMC.

Member, APIC.

Member, Position Control Team, SKMC.

Member, PGME, SKMC.

Member, Multi-payer Task Force.

Member, Champion Documentation Project, SKMC.

Member, SEHA/HAAD Health Audit Working Group.

Member, Strategic Emergency Preparedness Committee, SKMC.

Member, Grievance Committee, SKMC.

Member, SEHA Quality Forum.

Member, Chest Pain Accreditation Committee, SKMC.

Member, SEHA Mortality and Morbidity Committee

Member, SEHA Rapid Response Team.

Member, Senior Mangement Council, SKMC.

Member, Risk Management Committee, SKMC.

Member, Environment Health & Safety Management System (EHSMS) Strategic Committee

Member, Fifth Edition of JCI Standards: JCI Standards Advisory Panel Member.

Member, CUSP/CLABSI Task Force, SKMC.

Member, CAP Steering Committee Meeting, SKMC.

Member, Medical Executive Committee, SKMC.

Member, Clinical Chairs Committee, SKMC.
12
COMMITTEES

Member, Wellness Committee, SKMC.

Member, PSN Committee, SKMC.

Member, PSN Committee, SEHA.

Member, CAUTI Subcommittee, SKMC.

Chairman, Transformation Event Team.

Chairman, Real Time Patient Satisfaction Project.

Chairman, Excellence SKMC Committee, SKMC.

Chairman, EFQM SKMC Committee, SKMC.

Chairman, Lean Six Sigma Performance Improvement Committee, SKMC.

Chairman, Quality Champion Award, SKMC.

Member, SSI Subcommittee, SKMC.

Chairman, International Patient and Safety Goals.

Chairman, EFQM/DQA Writing Group.
13
EDITORIAL RESPONSIBILITIES

Editor of The Journal of Safety and Quality of the Joint Commission

Editorial Board - Open Access Journal of Clinical Trials

Review for the International Journal of Quality & Reliability Management

Reviewer of Clinical Cardiology

Reviewer of manuscripts for Chest

Reviewer of manuscripts for the Lancet

Reviewer of manuscripts for Circulation

Reviewer of manuscripts for Diabetes Care

Reviewer of manuscripts for American Heart Journal

Reviewer of manuscripts for the Southerm Medical Journal

Reviewer of manuscripts for Archives of Internal Medicine

Reviewer of manuscripts for Annals of Internal Medicine

Reviewer of manuscripts for Endocrinology and Metabolism

Reviewer of manuscripts for European Journal of Heart Failure

Reviewer of manuscripts for Congestive Heart Failure Journal

Reviewer of manuscripts for the Journal of Nuclear Cardiology

Reviewer of manuscripts for the Journal of Transplant Coordination

Reviewer of manuscripts for the Journal of Cardiovascular Pharmacology

Reviewer of manuscripts for the Journal of American College of Cardiology

Reviewer of manuscripts of Saudi Heart Journal
SPORTS ASSOCIATIONS

American Medical Tennis Association, Member

United States Masters Swimming, Member

United States Tennis Association, Member

Peter Burwash International Special Tennis Programs, Member

United States Table Tennis Association, Member

Virginia Happy Trails Running Club, Member

American Running and Fitness Association, Member
14
LANGUAGES

Fluent in English, French and Arabic
PERSONAL INTERESTS

Sports, public speaking,teaching, research, reading, community service, cooking.
AWARDED GRANTS
1.
The Role of Angiotensin in the pathophysiology of Atherosclerosis.
Funding source: MEDLANTIC RESEARCH INSTITUTE.
2.
Effect of a Soy on Brachial Reactivity in Post-menopausal Women.
Funding source: PROTEIN TECHNOLOGY.
3.
The effect of Non-selective Endothelin Receptor ET- A and ET-B Antagonism on The
Endothelial Function of Chronic Heart Failure.
Funding source: MEDLANTIC RESEARCH INSTITUTE.
4.
Study of PDE5 Inhibition on Myocardial ischemia and Vascular Function.
Funding source: MEDSTAR RESEARCH INSTITUTE.
15
SELECTED INVITED PRESENTATIONS

Risk Factors for Cardiovascular Disease and Stroke
Supported by the American Heart Association
February 26, 1993
Course Program Director
Hampton, VA

Washington Heart's Fifth Annual Symposium on Echocardiography
Echocardiography: Advances and Clinical Application.
Stress Echocardiography versus Myocardial Perfusion Scintigraphy
in Evaluation of Myocardial Ischemia
September 22-24, 1994
Hyatt Hotel, Bethesda, MD

Washington Heart's Sixth Annual Symposium on Echocardiography:
Advances and Clinical Applications
Symposium Co-director
Stress Echo: Role in Evaluation of PTCA and Determination of Restenosis.
September 22-24, 1995
Hyatt Hotel, Bethesda, MD

South Medical Association's 90th Annual Scientific Assembly
Noninvasive Evaluation of the Cardiac Patient Undergoing Noncardiac Surgery.
November 23, 1996
Baltimore, MD

Washington Health and Fitness Exposition
Risk Factors of Coronary Artery Disease.
January 25,1997
Washington, DC

Bacos Middle School
Cardiovascular Prevention
January 9, 1997
Washington. DC

Department of Anesthesia Grand Round
Washington Hospital Center
Preoperative Cardiovascular Risk Assessment.
April 8, 1997
Washington, DC

Management of Chronic Mitral Regurgitation in the Modern Era
Etiology and Pathophysiology of Chronic Mitral Regurgitation:
Interesting Cases.
May 31, 1997
Washington, DC
16
SELECTED INVITED PRESENTATIONS

Innovations in Medicine and Surgery
19th National AAMA Convention
Program Committee.
New Concepts in Cardiac Disease
Washington, DC

Moderator: Research Award Presentations.
Willard Hotel
August 28-31, 1997
Washington, DC

Pharmacological Innovations in The Management of Hypertension and Angina
Four Seasons Hotel
September 3, 1997
Washington DC

Echocardiography: The How-To of Image Acquisition and Quantitation
Teleconference
American College of Cardiology: Heart House
September 13,1997
Bethesda, MD

New Therapies for the Treatment of Hypertension and Angina
Northern Virginia Society of Osteopaths
September 16, 1997
Mc Lean Hilton, VA

Pharmacological Innovations in The Management of Hypertension and Angina
September 21, 1997
Tysons Corner Ritz Carlton, VA

Update on The diagnosis and Treatment of Congestive Heart Failure
September 23, 1997
Mount Vernon Hospital Grand Round, VA

Myocardial Revascularization (DMR)
September 15, 1997
Washington Hospital Center
Washington, DC

Relief of Septal Obstruction in Hypertrophic Cardiomyopathyby Transient
Occlusion of The First Septal Branch of the Left Anterior Artery and Septal
Reduction With Desiccated Ethanol Instillation-Live Demonstration
TCT
September 16, 1997
Washington, DC
17
SELECTED INVITED PRESENTATIONS

Transesophageal Echocardiographically-Guided Balloon Mitral Valvuloplasty
“Live Demonstration"
Transcatheter Cardiovascular Therapeutics (TCT)
September 24- 28, 1997
Washington, DC

Preoperative Cardiovascular Risk assessment
Medical Grand Round
October 17, 1997
Prince George Hospital
Cheverly, MD

Pharmacological Innovations in The Management of Hypertension and Angina
October 23, 1997
Old Town
Fredericksburg, MD

Update on The Diagnosis and Treatment of Congestive Heart Failure
Medical Grand Round
October 29, 1997
DC General Hospital
Washington, DC

Pharmacological Innovations In the Management of Hypertension and Angina
November 4, 1997
Baltimore, MD

Update on The Diagnosis and Treatment of Congestive Heart Failure
Medical Grand Round
November12, 1997
Potomac Hospital
Woodbridge, VA

Pharmacological Innovations In the Management of Hypertension and Angina
November 18, 1997
Georgetown
Washington, DC

Cardiac Contagion: Chlamydia Pneumoniae and Coronary Artery Disease
Medical Grand Round
October 17, 1997
Prince George Hospital
Cheverly, MD
18
SELECTED INVITED PRESENTATIONS

Congestive Heart Failure
Nurse Practitioner Conference
December 10, 1997
Washington Hospital Center
Washington, D.C.

Clinical Advantages of T-type Calcium Channel Blocking Agents
Medical Grand Rounds
December 12, 1997
Andrews Air force Base, VA

The Latest Anti-Hypertensive Therapies for Difficult to Regulate Patients
And the African-American Population
January 8, 1998
California, Maryland

Cardiac Contagion: Chlamydia Pneumoniae and Coronary Artery Disease
Medical Grand Rounds
Washington Hospital Center
January, 21, 1998
Washington, D.C.

New Therapies For Hypertension and Angina
February 17, 1998
Georgetown
Washington, D.C.

T-Channel Science and a New Compound For Treating Hypertension Angina
February 20, 1998
Oxford, Maryland

New Approaches to Cardiovascular Therapy: T-Type Calcium Channel Blocker in
Cardiovascular Therapy
Key Note Speaker, NVCNP Meeting
March 12, 1998
Falls Church, Virginia

New Advances in Antiplatelet Therapy
National Medical Naval Center
March 27,1998
Bethesda, Maryland

New Trends in Antiplatelet Therapy
April 16,1998
Baltimore, Maryland
19
SELECTED INVITED PRESENTATIONS

Neutral Endopeptidase Inhibitors in Heart Failure
Vascular Biology Conference
April, 17, 1998
Washington Hospital Center
Washington, D.C.

Update on Congestive heart Failure
April 23, 1998
Fort Belvoire Medical Grand Round, Virginia

New Trends in Antiplatelet Therapy
April 23, 1998
Ann Arundel Hospital Medical grand Round
Annapolis, Maryland

New Advances in Antiplatelet Therapy
May 5, 1998
Bethesda, Maryland

New Approaches to Cardiovascular Therapy: T-Type Calcium Channel Blocker in
Cardiovascular Therapy
May 9, 1998
Atlantic City, New Jersey

New Trends in Antiplatelet Therapy
May 12, 1998
Georgetown
Washington, D.C.

What’s New in Anti-platelet Therapy
Medical Grand Round
University of Maryland
May 27, 1998
Baltimore, Maryland

Management of Valvular Heart Disease in the Modern Era
Etiology and Pathophysiology of Chronic Mitral Regurgitation.
Interesting Cases.
May 29-30, 1998
Washington, D.C.

New Advancements In The Treatment of Hypertension and Angina
May 30, 1998
Richmond, Virginia

Update on Antiplatelet Management
June 2, 1998
Luthersville , Maryland
20
SELECTED INVITED PRESENTATIONS

Update on Congestive Heart Failure
Medical Grand Round
Greater South East Hospital
June 3, 1998
Washington, D.C.

JNC VI
Washington Hospital Center
June 4, 1998
Washington, D.C.

Antiplatelet Management
Medical grand Round
June 5, 1998
Adventist Hospital , Maryland

Update on Antiplatelet Therapy
June 22, 1998
Baltimore, Maryland

Update on Antiplatelet Therapy
Cardiology Rounds, Johns Hopkins Hospital
June 29, 1998
Baltimore, Maryland

New Advances in Antiplatelet Therapy
Medical Grand Rounds, Saint Joseph’s Hospital
July 15, 1998
Baltimore , Maryland

Treating the Difficult Hypertensive Patients
Holy Cross Department of Family Practice CME
October 5, 1998
Wheaton, Maryland

Evidence of Chalmydia Pneumoniae as a
Risk Factor For Coronary Artery Disease:
Status of Ongoing Antibiotic Clinical Trials
Transcatheter Cardiovascular Therapeutics
Tenth Annual Symposium
October 8, 1998
Washington, D.C.

Relief of Septal Obstruction in Hypertrophic Cardiomyopathy by Transient
Occlusion of The First Septal Branch of the Left Anterior Artery and Septal
Reduction With Desiccated Ethanol Instillation-Live demonstration
Left Ventricular Volume Reduction Surgery- Live Demonstration
Transcatheter Cardiovascular Therapeutics (TCT),
October 10, 1998
Washington, D.C.
21
SELECTED INVITED PRESENTATIONS

Understanding Myocardial Viability: Dobutamine Stress Echocardiography
Biosense LV Electromechanical Maps Training Course
Transcatheter Cardiovascular Therapeutics
Tenth Annual Symposium
October 11, 1998
Washington, D. C.

New Advances in Oral Antiplatelet Therapy
November 5, 1998
Washington, D. C.

Advances in the Prevention of Ischemic Vascular Events:
Antiplatelet Agents in Acute Coronary Syndromes.
ASHP Midyear Clinical Meeting,
December 6, 1998
Las Vegas, Nevada

Update on Antiplatelet therapy.
Cardiology Grand Rounds
Good Samaritan Hospital
January 12, 1999
Baltimore, MD

Endothelium, platelets and antiplatelet therapy
Cardiovascular pathophysiology conference
Howard University Medical Center
February 3, 1999
Washington, D.C.

Stress Echocardiography
Washington Hospital Center Grand Rounds
February 10, 1999
Washington, D.C.

Update on Antiplatelet trials: CURE and SYMPHONY II
Washington Hospital Center Emergency Room Rounds
February 18, 1999
Washington, D.C.

Coronary Artery Bypass Surgery and Angioplasty
National Rehabilitation Hospital Rounds
Februrary 18, 1999
Washington, D.C.

New Trends In Cardiovascular Risk factors
February 18, 1999
Georgetown
Washington, D.C.
22
SELECTED INVITED PRESENTATIONS

Cardiac Rehabilitation
National Rehabilitation Hospital Grand Rounds
February 26, 1999
Washington, D.C.

New cardiovascular Risk Factors: Homocysteine
April 9, 1999
Washington hospital Center
Washington, D.C.

Update on Antipaltelet Therapy
April 8,1999
Washington, D.C.

National Antiplatelet Therapy Update Meeting
Moderator
April 11-12, 1999
Naples, Florida

Update on Antipaltelet Therapy
May 21,1999
Pennsylvania

Update on theTtreatment of Obesity
June 15,1999
Richmond, VA

Moderator: Cardiology Morning Session, NAAMA 16th International Medical
Convention
July 1999
Beirut, Lebanon.

Obesity and Heart Disease
August 4,1999
Alexandria , VA

Evolving Treatment of Acute Coronary Syndromes: New Agents and
Applications
Course Director
September 8, 1999
Baltimore, Maryland

Endothelial Dysfunction in Hypertensive Patients
Vascular Biology Conference
Washington Hospital Center
September 10,1999
Washington, D.C.
23
SELECTED INVITED PRESENTATIONS

Obesity and Heart
September 14,1999
Bethesda, Maryland

Update on Vascular Biology
Cardiology Grand Rounds
Howard University Medical Center
September15, 1999
Washington, D.C.

Atherosclerosis
National Rehabilition Hospital
September 21,1999
Washington, D.C.

Endothelium, Platelets and Antiplatelet therapy
October 12,1999
Baltimore, MD

Chairman: Basic Science
12th Annual Meeting
October 19-22, 1999
Mediterranean Association of Cardiology and Cardiac Surgery
Damascus, Syria

Angiotensin and the Endothelium
November 4, 1999
Georgetown
Washington, D.C.

Angiotensin and the Endothelium
December 7, 1999
Washington, D.C.

The Patient With Atherothrombosis: Preventing Ischemic Event
December 15, 1999
Walter Reed Army Medical Center Neurology Grand Rounds
Washington, D.C.

Current Management of Myocardial Infarction
December 17, 1999
National Institute of Health
Bethesda, MD

Endothelin Inhibitors and Heart Failure:
Vascular Biology Conference
September 15, 2000
Washington Hospital Center
Washington, D.C.
24
SELECTED INVITED PRESENTATIONS

Inflammation, HsCRP and Atherosclerosis:
Vascular Biology Conference
October 13, 2000
Washington Hospital Center
Washington, D.C.

Exercise and Heart Failure:
Endothelial mechanisms for symptomatic improvement
Vascular Biology Conference
November 17, 2000
Washington Hospital Center
Washington, D.C.

Aldosterone Receptor Antagonists and Heart Failure
Vascular Biology Conference
December 15, 2000
Washington Hospital Center
Washington, D.C.

Vasopeptidase Inhibitors and Heart Failure
Vascular Biology Conference
January 19, 2001
Washington Hospital Center
Washington, D.C.

Antiplatelet Therapy Managed Care Clinical Forum:
Atherosclerotic Disease and Antiplatelet Therapy
February 15, 2001
Baltimore, Maryland

Peripheral Arterial Disease
Vascular Biology Conference
February 16, 2001
Washington Hospital Center
Washington, D.C.

Exercise and Heart Failure
Medical Grand Round
National Rehabilitation Hospital
March 2, 2001
Washington, D.C.
25
SELECTED INVITED PRESENTATIONS

Pregnancy and the Heart
Pathophysiology Conference
March 16, 2001
Washington Hospital Center
Washington, D.C.

Update on Antiplatelet Therapy
Medical Grand Round
March 21,2001
DC General Hospital
Washington, D.C.

Hyperthyroid Heart Disease
March 23,2001
North Arundel Hospital, MD

Update on Heart Disease : Diagnosis and Treatment
March 25, 2001
Northern VA AAMA Community Outreach
Fairfax , VA

Common Cardiac Diagnoses
April 2, 2001
National Rehabilitation Hospital
Washington, D.C.

Components of a Complete TEE: Technical Tips and Pearls
Washington Hospital Center
April 12, 2001
Washington, D.C.

Atherosclerotic Cardiovascular Disease: An update
July 31, 2001
Saint Petersburg, Florida

Managed Care and Antiplatelet Therapy
August 1, 2001
Dearbon, Michigan

Oral Antiplatelet Therapy: An Update
Medical Grand Round
August 3, 2001
Prince George County Hospital, Maryland

Oral Antiplatelet Therapy: An Update
August 7, 2001
Phoenix, Arizona
26
SELECTED INVITED PRESENTATIONS

Exercise and Heart Failure
PNMR Grand Round
August 20, 2001
Walter Reed Army Medical Center
Washington, D.C.

Peripheral Artery Disease: Diagnosis & Management
August 14, 2001
Buffalo, New York

Oral antiplatelet Therapy
And Acute Coronary Syndrome
Family Medicine Grand Round
August 15, 2001
Howard University Medical Center
Washington, D.C.

Oral Antiplatelet Therapy and Managed Care
August 16, 2001
Washington, Seattle

Antiplatelet Therapy and Acute Coronary Syndrome
Medical Grand Rounds
Kimberough Medical Center
September 5, 2001
Fort George G. Meade, Maryland

Management of Acute Coronary Syndromes
Prince George Hospital
Medical Grand Round
October 17, 2001
Prince George County, MD

Management of Acute Coronary Syndromes
Good Samaritan Hospital
Medical Grand Round
October 22, 2001
Baltimore, MD

Management of Acute Coronary Syndromes
October 24, 2001
Baltimore, Maryland

Acute Coronary Sydromes
October 26, 2001
Andrews Airforce Base Medical Center
Maryland
27
SELECTED INVITED PRESENTATIONS

Update on the Management of Acute Coronary Syndromes
November 7, 2001
Washington, D.C.

Atherothrombosis Summit
Course Director
Epidemiology and Pathophysiology of Atherothrombosis
Advances in the Management of Vascular Events
Treatment Modalities of Acute Coronary Syndromes
High-Risk Patient Workshop
November3-4, 2001
Atlanta, Georgia

Oral Antipaltelet Therapy and Acute Coronary Syndrome
March 22, 2002
Washington, D.C.

Update on the Management of Acute Coronary Syndromes
March 23, 2002
Hanover, Maryland

Update on the Management of Acute Coronary Syndromes
April 4, 2002
Holidaysburg, Pennsylvania

Update on Intaroperative Transesophageal Echocardiography
Anesthesia Grand Round
George Washington University Medical Center
April5,2002
Washington, D.C.

Acute Coronary Syndromes
Medical Grand Round
Howard University Medical Center
April17,2002
Washington, D.C.

Acute Coronary Syndromes
Emergency Room Grand Round
Providence Hsopoital
April17,2002
Washington, D.C.
28
SELECTED INVITED PRESENTATIONS

Exercise and Heart Failure
Medical Grand Rounds
May 3, 2002
Virginia Hospital Center
Arlington,Virginia

Update on Systemic Hypertension
May 15, 2002
Wilimington, Delaware

Update on Systemic Hypertension
May 17, 2002
Delaware Beach, Delaware

Update on Systemic Hypertension
May 17, 2002
Rebobath Beach, Delaware

Update on the Management of Acute Coronary Syndromes
March 23, 2002
Hanover, Maryland

Update on Systemic Hypertension
June 5, 2002
Delaware Beach, Delaware

Update on Systemic Hypertension
May 6, 2002
Newark, Delaware

Update on Management of Hyperlipidemia
June 6, 2002
Ocean City, Maryland

Hyperlipidemia: What’s New?
Ritz Carlton
June 18, 2002
Tyson’s Corner, Virginia

Update on the Management of Acute Coronary Syndromes
June 24, 2002
California, Maryland

Update on Systemic Hypertension for the Community
July 8, 2002
Virginia Hospital Center
Arlington, VA
29
SELECTED INVITED PRESENTATIONS

Update on the Management of Acute Coronary Syndromes
August 27, 2002
Atlanta, Georgia

Update on the Management of Acute Coronary Syndromes
June 24, 2002
Miami, Florida

Update on Systemic Hypertension
September 10, 2002
Falls Church, Virginia

Update on the Management of Acute Coronary Syndromes
September 13, 2002
Howard University Medical Center
Washington, D.C.

Management of Systemic Hypertension in Diabetic Patients
January 30,2003
Chevy Chase, MD

Advances in the Management of Patients with Acute Coronary Syndromes
Inova Alexandria Hospital Medical Staff Meeting
February 4,2003
Alexandria, VA

Update on the Management of Acute Coronary Syndromes
Center Community Hospital
February 12, 2003
State College, PA

Update on the Management of Systemic Hypertension in Patients with Diabetic
Nephropathy
February 26, 2003
Vienna, VA

Acute Coronary Syndromes: Update on the AHA/ACC Guidelines
Providence Hospital
March 27, 2003
Washington, D.C.

New ACC/AHA Guidelines: Management of Acute Coronary Syndrome Patients
Philippino American Medical Society
March 30, 2003
Baltimore, MD

Update on the Management of Acute Coronary Syndrome
March 31, 2003
Baltimore, MD
30
SELECTED INVITED PRESENTATIONS

Acute Coronary Syndromes: Focus on NSTEMI/UA
April 1, 2003
Cincinatti, Ohio

Acute Coronary Syndromes: Focus on Antipltelet Therapy
April 2, 2003
Cincinatti, Ohio

Acute Coronary Syndromes: New ACC/AHA Guidelines
April 3, 2003
Cincinatti, Ohio

Update on Antiplatelet Therapy
April 11, 2003
Somerset Area Hospital
Somerset, Pennsylvania

Update on the Management of Patients with Chronic Heart Failure
April 18, 2003
Georgetown University Medical Center
Washington, D.C.

Update on the Management of Hypertension in Patients with Diabetic Nephropathy
April 23, 2003
Charlottesville, VA

Management of Patients with Hypertension and Diabetes Mellitus
Medical Grand Round
May 9, 2003
Vrginia Hospital Center
Arlington, VA

Systemic Hypertension in Patients with Diabetic Nephropathy
May 13, 2003
Tyson’s corner, VA

Advances in the Management of Acute Coronary Syndromes and Changes in the
ACC/AHA Guidelines: CME Program
May 14, 2003
State College, PA

Update on the Management of Hyperlipidemia in Patients with Coronary Artery Disease
May 19, 2003
Baltimore, MD

New Trends in the Acute and Long-term Management of Patients with Acute Coronary
Syndromes
May 27, 2003
Johnstown, PA
31
SELECTED INVITED PRESENTATIONS

Management of Patients with Hypertension and Diabetes Mellitus
K. Memorial Center, Housestaff Conference
May 28, 2003
Johnstown, PA

Update on the Management of Patients with Hypertension and Diabetes Mellitus
May 28, 2003
Johnstown, PA

Management of Patients with Peripheral Artery Disease
June 2, 2003
Philsburg, PA

Acute Coronay Syndromes: New ACC/AHA Guidelines
June 4, 2003
East Petersburg, PA

New Trends in the Evaluation and Management of Patients with Acute Coronary
Syndrome: Medical Grand Round, Conemaugh Memorial Hospital
June 6, 2003
Johnstown, PA

Acute Coronary Syndrome: Update on Antithrombotic Therapy
June 11, 2003
Mount Carmel, PA

The Long Term Management of Diffuse Atherothrombosis
Nurse Practitioner Society of Maryland
June 12, 2003
Bethesda, Maryland

Antiplatelet Therapy: Focus on Acute Coronary Syndromes
June 18, 2003
Johnston City, TN

Antiplatelet Therapy: Focus on Acute Coronary Syndromes
Johnston City Medical Center
Cardiac Catheterization Conference
June 18, 2003
Johnston City, TN

Management of Patients with Acute Coronary Syndromes: Case Discussion and Update
June 24, 2003
Radnor, PA

Update on Diagnosis and Treatement of Dyslipidemia
May 19, 2004
Southern Maryland
32
SELECTED INVITED PRESENTATIONS

Update on Dyslipidemia
May 21, 2004
Fairafx, VA

New Trends in the Diagnosis and Management of Acute Coronary Syndrome
Medical Grand Round
June 2, 2004
York Memorial Hospital
York, Pennsylvania

Update on the Management of Acute Coroanry Syndrome
Cardiology Grand Round
June 5, 2004
Hershey Medical Centre
Hershey, Pennsylvania

Acute Coronary Syndromes
June 9, 2004
Harrisburg, PA

Acute Coronary Syndromes
Medical Grand Round
Du Bois Medical Center
June18, 2004
Du Bois, PA

Advances in the Diagnosis and Management of Acute Coronary Syndrome
August 3, 2004
Pittsburg, PA

Longterm Treatment of Patients with Acute Coronary Syndrome
August 4, 2004
Cleveland, Ohio

New trends in the Magement of Acute Coronary Syndrome
August 4, 2004
Cleveland, Ohio

Update on Chest Pain Diagnosis and Management
Medical Grand Round
Radar Clinic
August 18, 2004
Arlington, VA

Update on Peripheral Arterial Disease
Cardiology Grand Round
Elmhurst Hospital Center
August 19, 2004
Elmhurst, NY
33
SELECTED INVITED PRESENTATIONS

A Risk-Based Approach to Managing Patients With Cardiovascular Disease (CME)
Medical Grand Round
York Memorial Hospital
February 2, 2005
York, PA

A Risk-Based Approach to Managing Patients With Cardiovascular Disease (CME)
Medical Grand Round
Gettysburg Hospital
February 5, 2005
Gettysburg, PA

Longterm Management of Acute Coronary Syndrome Patients
Wrightsville, PA
February 7, 2005

Discussion on the Management of Acute Coronary Syndromes
February 10, 2005
Lancaster, PA

Update on Acute Coronary Syndromes
Cardiology Garnd Round
Sunny Downstate University Hospital
February 22, 2005
Brooklyn, NY

Update on Acute Coronary Syndromes: Preoperative and postoperative care
Cardiac Surgical Intensive Care Unit Round
Sunny Downstate University Hospital
February 22, 2005
Brooklyn, NY

Update on Acute Coronary Syndromes
February 22, 2005
Long Island, NY

Advances in the Management of Acute Coronary Syndromes
March 1, 2005
Harrisburg, PA

Advances in the Management of Acute Coronary Syndromes
March 9, 2005
Great Neck, NY

Advances in the Management of Acute Coronary Syndromes
March 10, 2005
Garden City, NY
34
SELECTED INVITED PRESENTATIONS

Advances in the Management of Acute Coronary Syndromes
Surgical Grand Round
Brookdale Hospital
March 13, 2005
Brooklyn, New york

Advances in the Management of Acute Coronary Syndromes
March 15, 2005
Windber, PA

Advances in the Management of Acute Coronary Syndromes
Surgical Grand Round
Brookdale Hospital
March 24, 2005
Brooklyn, NewYork

Managing the Broad Range of High Risk Patients
September 6, 2005
Centerville, Virginia

Update on The Management of Acute Coronary Syndrome
November 16th, 2005
Miami Beach, FL

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
January 19th, 2006
Fort Washington, MD

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
NOVA Internal Medicine& Urgent Care
January 20th, 2006
Ashburn, VA

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
January 26 th, 2006
Annapolis, MD

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
March 2, 2006
Winchester,Virginia

Advances in Heart Failure Therapy:
March 3, 2006
Frederick, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
March 4, 2006
Pittsburg, Pennsylvania
35
SELECTED INVITED PRESENTATIONS

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
March 7, 2006
Atlanta, Georgia

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
March 8, 2006
Falls Church, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
March 9, 2006
New Brunswick, New Jersey

Understanding Hypertension and Type 2 Diabetic Nephropathy with
Hypertension
March 13, 2006
Alexandria, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
March 21, 2006
LaPlata,Maryland

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
March 23, 2006
Maimi Beach, Florida

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
March 24, 2006
Miami, Florida

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
South Miami Hospital
March 24, 2006
Miami ,Florida

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
March 27, 2006
Houston, Texas

Understanding Hypertension: Prevalence, Guidelines and Risks
March 29, 2006
Annapolis, Maryland

Advances in Heart Failure Therapy:
March 30, 2006
Frederick, Maryland
36
SELECTED INVITED PRESENTATIONS

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
April 3, 2006
Midlothian, Virginia

Key Note Speaker
Career Day
National Honor Society
April 11, 2006
Alexandria, VA

Confront the Challenge: Treating Patients to Their Dylipidemia Goals
April18, 2006
Olney, Maryland

Understanding Hypertension: Prevalence, Guidelines and Risks
April 19, 2006
LaPlata, Maryland

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
April 25, 2006
Saint Michaels, Maryland

Optimizing Treatment of Dyslipidemia in Patients with Type 2 Diabetes Mellitus
Annapolis Internal Medicine
April 26, 2006
Annapolis, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
April27, 2006
Saint Loius, MO

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
May 3, 2006
Clifton Springs, New York

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
May 5, 2006
Norfolk, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
May16, 2006
Hagerstown, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
May 18, 2006
Allentown, Pennsylvania
37
SELECTED INVITED PRESENTATIONS

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.
Primed Update
May 20, 2006
East Rutherford, New Jersey

STEMI Management Strategies for Non-Cath-Lab Hospitals Program
June 1, 2006
Clarksburg, West Virginia

Advances in Heart Failure Therapy:
June 3, 2006
Vienna, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
June7, 2006
Frederick, Maryland

Insulin Therapy in Treating Critically Ill Patients: What are the Potential Benefits?
Primed Cardiology Update
June 10, 2006
Itasca, Illinois

Managing the Broad Range of High Risk Patients
June 13, 2006
Arlington, Virginia

Peripheral Arterial Disease: Identification and Mangement of Risk
Williamsport Hospital
June 15, 2006
Williamsport, Pennsylvania

Visceral Fat an Emerging Endocrine Organ: Effects on cardiometabolic risk.
Primed Update
June 17, 2006
Vienna, Virginia

Update on Atheroscerolic Peripheral Arterial Disease
August 16, 2006
Bricktown, New Jersey

Advanced Management of Cardiovascular Disease: Reducing the Burden of Risk
Franklin Square Hospital
August29,2006
Baltimore, MD

Understanding Hypertension: Prevalence, Guidelines and Risks
August 31, 2006
Richmond, VA
38
SELECTED INVITED PRESENTATIONS

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid
System
Atlanta VA Medical Center
Emory University Hospital Affiliate
September 7, 2006
Atlanta, Georgia

Understanding Hypertension:Prevalnce, Guidelines and Risks
September 12, 2006
Lexington Park, Maryland

Understanding Hypertension:Prevalnce, Guidelines and Risks
September 14, 2006
Buffalo, New York

Primary and Secondary Stroke Prevention:Pathways of Care
Greenville Memorial Hospital
Rehabilitaion Grand Round
September 16,2006
Greenville, South Carolina

Adavanced Management of Cardiovascular Disease: Reducing the Burden of Risk
Cardiac Catheterization Conference
Harrisburg Hospital
September 18, 2006
Harrisburg, Maryland

Acute Coronary Syndrome
Krembs Cardiac Teaching Day
Continuing Medical Education
September 21, 2006
Binghampton, New York

Adavanced Management of Cardiovascular Disease: Reducing the Burden of Risk
September 26, 2006
New Milford, New Jersey

Management of Patients with STEMI:Applying the ACC/AHA Guidelines
Continiung Medical Education
Medical Grand Round
Sptember 26, 2006
New Milford, New Jersey

Bergen Regional Medical Center
September 27, 2006
Paramus, New Jersey
39
SELECTED INVITED PRESENTATIONS

In-Hospital Hyperglycemia in Type 2 Diabetes Edirorial Working Group
NSTEMI Update
October 20, 2006
Atlanta, Georgia

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid
System
Primed Meeting
October 27, 2006
Durham, North Carolina
.
Management of ST-Elevation Myocardial Infarction: Focus on the Thrombolytic
Approach.
December 5, 2006
Manassa, VA


Insulin Therapy in Treating Critically Ill Patients: What are the Potential Benefits?
Primed Cardiology Update
December 9 , 2006
Miami, Florida

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Samaritan Medical Center
December 11, 2006
Watertown, NY

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Washington, D.C.
December 12, 2006.

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
December 12, 2006
Waterville, ME

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
January 9, 2007
Washington, D.C.

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Montgomery General Hospital
January 11, 2007
Olney, Maryland

Acute Coronary Syndrome: Non- ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
January 17, 2007
Washington, D.C.
40
SELECTED INVITED PRESENTATIONS

Acute Coronary Syndrome: Non- ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
January 23, 2007
Washington, D.C.

Acute Coronary Syndrome: Non- ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
January 26, 2007
Washington, D.C.

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
February 1, 2007
Washington, D.C.

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Montgomery General Hospital
VAMC
February 2, 2007
Wilkes Barr, PA

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
February 7, 2007
Washington, D.C.

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid
System
Medical Grand Round
February 8, 2007
Dalton, GA

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Greater South East Community Hospital
February 14, 2007
Washington, D.C.

Update on Peripheral Arterial Disease
February 16, 2007
West Palm Beach, FL

New Data on Acute Coronary Syndromes
Cardiac Cath Conference
JFK Medical Center
February 17, 2007
Atlantis, Florida
41
SELECTED INVITED PRESENTATIONS

Update on Atherothrombosis
Department of Medicine Round
Prince George Hospital
February 20, 2007
Hyatsville, Maryland

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid
System
Salisbury Hospital
Medical Grand Round
February 27, 2007
Salisbury, MD

Update on Atherothrombosis: Make the Connection
March 1, 2007
Rochester, New York

Update on Hypertension:
March 6, 2007
Emporia, VA

Update on Hypertension
March 8, 2007
Rochester, New York

New Data on Acute Coronary Syndromes
March 15, 2007
Johnstown, PA

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
March 19, 2007
Washington DC

Atherothrombosis and Peripheral Arterial Disease: Making the Connection
March 20, 2007
Bethesda, Maryland

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
March 20, 2007
Washington, D.C.

Coronary Interventions in Acute Coronary Syndrome
Clara Mass Medical Center
March 21, 2007
Newark, NJ
42
SELECTED INVITED PRESENTATIONS

Atherothrombosis: New Data on Acute Coronary Syndrome
March 21, 2007
Paramus, NJ

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
March 22, 2007
Washington, D.C.

Atherothrombosis: New Data on Acute Coronary Syndrome
March 22, 2007
New Castle, PA

Atherothrombosis: New Data on Acute Coronary Syndrome
March 22, 2007
Erie, PA

Atherothrombosis Make The Connection: A Focus on Peripheral Arterial Disease.
March 22, 2007
Leesburg, VA

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
April 3, 2007
Abu Dhabi, UAE

Diabetes and Cardiovascular Disease: Glycemic Control and Insulin Therapy.
Medical Grand Rounds
SKMC Medical Center
April 5, 2007
Abu Dhabi, UAE

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
April 12, 2007
Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
April 17, 2007
Abu Dhabi, UAE

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
April 19, 2007
Abu Dhabi, UAE

Treatment Startegies for Hypertensive Patients Not at Their Goal on One Agent
National Expert Exchange Teleconference
April 23, 2007
Abu Dhabi, UAE
43
SELECTED INVITED PRESENTATIONS

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
April 24, 2007
Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
April 26, 2007
Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
May 1, 2007
Washington DC



Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
ay 3 , 2007
Washington DC
Treatment Strategies in Patients with Hypertension Who are Not at their Blood Pressure
Goal
May 8, 2007
Fredricksburg, VA
Atherothrombosis and Acute Coronary Syndromes
May 9, 2007
Cumberland, MD

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
May 10 , 2007
Washington DC

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
May 11, 2007
Washington DC

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
May 16 , 2007
Washington DC

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid
System
Salisbury Hospital
February 17, 2007
Medical Grand Round
44
SELECTED INVITED PRESENTATIONS

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
Washington DC
May 17, 2007

Coronary Interventions For Acute Coronary Syndromes: From Acute to Long-Term
Management
Research medical Center
May 23, 2007
Kansas, MO

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
May 23 , 2007
Washington DC

Coronary Interventions For Acute Coronary Syndromes: From Acute to Long-Term
Management
Mary Washington Hospital
May 25, 2007
Fredericksburg, VA

Atherothrombosis Make The Connection: A Focus on Peripheral Arterial Disease.
June 7, 2007
Arlington, VA

Applying Updated ACC/AHA Guidelines For Unstable Angina, NSTEMI and STEMI
June20, 2007
Emergency Room, Kansas City, Missouri

Atherothrombosis: New Data on Acute Coronary Syndrome
Medical Grand Round
June20, 2007
Kansas City, Missouri

Reducing Acute Risk in the Non-Stented Patient with ACS (NSTEMI)
June20, 2007
Kansas City, Missouri

A Conversation on the Challenges to Caring for UA/NSTEMI Patients
Sheraton Premier
June 25, 2007
Tyson’s Corner, VA

ARB's in Hypertension and Heart Failure: Consider the Evidence
June 27, 2007
Bethesda, MD
45
SELECTED INVITED PRESENTATIONS

Acute Coronary Syndrome: Non- ST Elevation Myocardial Infartcion
National Expert Exchange Teleconference
June 27, 2007
Washington, DC

A Conversation on the Challenges to Caring for UA/NSTEMI Patients
July 17, 2007
Virginia Beach, Virginia

Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension
July 17, 2007
New Jersey, NY

Treatment Strategies In Patients With Hypertension Who Are Not At Their Blood Pressure
Goal
July 18, 2007
New Jersey, NY

Understanding Hypertension And Type 2 Diabetic Nephropathy With Hypertension
July 18, 2007
River Pam, New Jersey

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
July 30 , 2007
Washington DC

Atherothrombosis Make The Connection:
ACS, PAD and Stroke
August 9, 2007
Springfield, Virginia

Management of Patients With STEMI: Applying the ACC/AHA Guidelines
Medical Grand Round
January 11, 2007
Ogdensburg, New York

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
July 30, 2007
Washington, DC

Atherothrombosis Make the Connection: ACS, PAD and Stroke
Medical Alliance
August 9, 2007
Springfield, Virginia
46
SELECTED INVITED PRESENTATIONS

Reducing Acute Risk in the Non-Stented Patient with ACS (NSTEMI)
Medical Grand Rounds
August 20, 2007

Atherothrombosis Make the Connection: New Clinical Data in Patients with ACS
August 30, 2007
Delray Beach, Florida

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
Sept. 5, 2007
Washington DC

Current and Emerging Strategies For the Management of Cardiometabolic Risk
PriMed Update CME meeting
Sept. 15, 2007
San Antonio, TX

Maximizing Efficacy, Minimizing Risk: Applying New Results From ACS Registries to
Improve Patient Outcomes
Saint Vincent Charity Hospital
Medical Grand Rounds
September 26, 2007
Cleveland, Ohio

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
October 18, 2007
Washington, DC

Applying The ACC/AHA Guidelines for Acute Coronary Syndrome in Clinical Practice
Medical Grand Round
Virginia Hosptial Center
October 19, 2007
Arlington, Virginia

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes
National Expert Exchange Teleconference
October 31, 2007
Washington, DC

Current and Emerging Strategies for Reducing Cardiometabolic Risk
Georgetown University Hospital
Medical Grand Round
November 1, 2007
Washington, DC
47
SELECTED INVITED PRESENTATIONS

Current and Emerging Strategies for the Management of Cardiometabolic Risk
PriMed CME Update Meeting
November 3, 2007
Orlando, Florida

Pre- Hospital and Emergency Room Mangement of STEMI
Medical Grand Round
November 21 , 2007
VAMC, Wilmington, Delaware

CTA: Guidance of Cardothoracic Surgery
December 3, 2007
Washington DC

CTA: Integration Into Cardiology Daily Practice
December 6,2007
Washington DC

CTA: 2007 Update
December 11, 2007
Washington DC

CTA: Understanding The Basics
December 27,2007
Washington DC

The Society of Endocrinology and Metabolism of Turkey
Advancement in Type 2 Diabetes Management
4th Roses Assembly
Co-Chairman
April 31-May 2, 2008
Antalya, Turkey

The Pathogenesis and Clinical Impact of Atherosclerosis: A Case Scenario
May 6, 2008
Abu Dhabi, UAE

Update in the Treatment of Cardiovascular Disease Symposium
Role of CT angiography before and after CABG surgery
May 9, 2008
Abu Dhabi, UAE

Update on Heart Failure HFSA Guidelines
August 19, 2008
June 11, 2008
SKMC
Abu Dhabi, UAE
48
SELECTED INVITED PRESENTATIONS

Peripheral Artery Occlusive Disease:
An Interactive Case Discussion
August 19, 2008
SKMC
Abu Dhabi, UAE

Emirates Society of Cardiology
Heart Failure In The Middle East
October 24, 2008
Abu Dhabi, UAE

Smoking Cessation Work-Shop
Chairman
October 24, 2008
Abu Dhabi, UAE

Smoking Cessation Work-Shop
Health Risks of Smoking and Health Benefits of Smoking Cessation
October 24, 2008-11-25
Abu Dhabi, UAE

Combination Therapy In Systemic Hypertension:
October 31, 2008
Limassol, Cyprus

Role of Beta Blockade in the Management and Prevention of Cardiovascular Diseases
Chairman
November 14, 2008
Dubai, UAE

Role of Beta Blockade in the Management and Prevention of Cardiovascular Diseases
Case Studies
November 14, 2008
Dubai, UAE

Third International Congress of Cardiology: Multi-Modality Imaging
CTA Angiography and CABG
November 14, 2008
Dubai, UAE

HsCRP: Past, Present and Future
November 23, 2008
SKMC
Abu Dhabi, UAE

First Arab Health : Clinical Cardiology
Chairman
January 26 – 27, 2009
Dubai, UAE
49
SELECTED INVITED PRESENTATIONS

First Arab Health : Clinical Cardiology
Update on Diagnosis and Management of Heart Failure
January 26, 2009
Dubai, UAE

First Arab Health : Clinical Cardiology
Case Discussion
January 27, 2009
Dubai, UAE

Update on Direct Renin Inhibitors
February 4, 2009
Kuwait, Kuwait

Update on The Angiotensin Renin Aldosterone Syndromw
February 6, 2009
Al Salama Hospital International Symposium
Abu Dhabi, UAE

Update on Heart Failure For Primary Care:
Chairman
Update on the Daignosis of Heart Failure
Interesting Cases
February 14, 2009
Abu Dhabi, UAE

KPI’s For Nurses
March 1, 2009
SKMC
Abu Dhabi, UAE

Cardiovascualr Disease Prevention Forum
Moderator
April 22, 2009
Abu Dhabi, UAE

Update on Beta Blockers
Chairman
Muscut, Oman
April 24-25, 2009

Update on Direct Renin Inhibitors
May 8, 2009
Abu Dhabi, UAE

Case Presentation Workshop
May 9, 2009-05-17
Abu Dhabi, UAE
50
SELECTED INVITED PRESENTATIONS

Update on the Diagnosis and Management of Systemic Hypertension
May 10, 2009
Abu Dhabi, UAE

Daman Second Annual Meeting : Medical Error Workshop
May 19 - 20, 2009
Abu Dhabi, UAE

Update on Cardiovascular Therapy
May 21, 2009
Larnaka, Cyprus

Direct Renin Inhibitors: New Therapeutic Options for Hypertesion
June 5, 2009
Dubai, UAE

Workshop on Cardiovascular Disease in Diabetic Patients
June 6, 2009
Abu Dhabi, UAE

Workshop on Cardiovascular Disease in Diabetic Patients
June 6, 2009
Abu Dhabi, UAE

Culture of Safety
June 15, 2009
Abu Dhabi, UAE

Cleveland Clinic and SKMC Cardiovascular Conference
Co-Chairman
January 25-27, 2010
Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular Conference
Mangement of Lower Extremity Arterial Disease:Intervention vs. Medical Management
January 25, 2010
Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular Conference
Moderator: Heart Failure Session
January 25, 2010
Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular Conference
Case Presentations: Heart Failure Session
January 25, 2010
Dubai, UAE
51
SELECTED INVITED PRESENTATIONS

Cleveland Clinic and SKMC Cardiovascular Conference
How to Manage Patients with Type 2 Diabetes While Minimizing Cardiovascular Risks and
Complications
January 27, 2010
Dubai, UAE

SKMC and Cleveland Clinic Quality Conference
Chairman
January 27-28, 2010
Dubai, UAE

SKMC and Cleveland Clinic Quality Conference
Tomorrow’s Medicine Today: The Elusive Role of Quality
January 28, 2010
Dubai, UAE

First Vascular Conference
Morbidity and Mortality
March 9, 2010
Abu Dhabi, UAE

First Vascular Conference
Quality Measures in Cardiovascular Disease
March 12, 2010
Abu Dhabi, UAE

Update on Hypertension Management with Fixed Dose Combination
March 22, 2010
Damascus, Syria

Update on Hypertension Management with Fixed Dose Combination
March 23, 2010
Aleppo, Syria

Oman Heart Association and Emirate Cardiac Society
The 33 rd Sicetific Session
The Jupiter Trial: Clinical Implications For Patient Management
April 1, 2010
Muscat, Oman

Oman Heart Association and Emirate Cardiac Society
The 33 rd Sicetific Session
What Every Physician Needs To Know About Quality In Healthcare
April 1, 2010
Muscat, Oman

Update on Hypertension Management with Fixed Dose Combination
March 23, 2010
Aleppo, Syria
52
SELECTED INVITED PRESENTATIONS

The Angiotensin-Renin-System-Efficay of Direct Renin Inhibitors: The Experience at the
Gulf Region
May 14, 2010
Dubai, UAE

Clinical Hypertension Cases Discussion
May 14, 2010
Dubai, UAE

Core Measures/Clinical Starter Sets Education
May 31, 2010

Hospital Build: Quality & Accreditation Conference
Chairman
June 1-3, 2010
Dubai, UAE

EFQM Workshop
June 2, 2010
Dubai, UAE

New 4th Edition JCI Standards
July 26, 2010
Abu Dhabi, UAE

International Safety Goals
Mangement Meeting
August 23, 2010
SKMC
Abu Dhabi, UAE

New 4th Edition JCI Standards
August 1, 2010
Abu Dhabi, UAE

New 4th Edition JCI Standards
August 8, 2010
Abu Dhabi, UAE

New 4th Edition JCI Standards
August 15, 2010
Abu Dhabi, UAE

New 4th Edition JCI Standards
August 22, 2010
Abu Dhabi, UAE
53
SELECTED INVITED PRESENTATIONS

JCI Accreditation
International Safety Goals
August 31, 2010
Abu Dhabi, UAE

International Safety Goals
Medical Staff Meeting
SKMC
September 15, 2010
Abu Dhabi, UAE

New 4th Edition JCI Standards
September 30, 2010
Abu Dhabi, UAE

Achieving Business Excellence Through EFQM Model
October, 2010
Abu Dhabi, UAE

International Patient Safety Conference
Chairman
October 16-18, 2010
Abu Dhabi, UAE

Benchmarking for Hospitals
November, 2010
Abu Dhabi, UAE

Infection Control Update
Chairman
January 10, 2011
Abu Dhabi, UAE

Update on the Mangement of Acute Coronary Syndrome
January 10, 2011
Abu Dhabi, UAE

Accreditation and quality: Role of the Cath Laboratory
January 11, 2011
Abu Dhabi, UAE

Internatioanl Arab Health Cardiology Conference
Chairman
January 24-25, 2011
Dubai, UAE
54
SELECTED INVITED PRESENTATIONS

Internatioanl Arab Health Cardiology Conference
Moderator: Quality Management in Healthcare
January 24, 2011
Dubai, UAE

Internatioanl Arab Health Cardiology Conference
Moderator: Management of Quality
January 24, 2011
Dubai, UAE

Internatioanl Arab Health Cardiology Conference
Determining the Role of Quality Department in Healthcare
January 24, 2011
Dubai, UAE

Healthcare Quality Measure - Key Performance Indicators
January 24, 2011
Dubai, UAE

Internatioanl Arab Health Cardiology Conference
Moderator: Healthcare Quality and Accreditation
January 25, 2011
Dubai, UAE

Internatioanl Arab Health Cardiovascular Conference
Chairman
January 26-27, 2011
Dubai, UAE

Internatioanl Arab Health Cardiolovascular Conference
Reactive Hyperglycemia and Cardiovascular Disease
January 26, 2011
Dubai, UAE

Internatioanl Arab Health Cardiolovascular Conference
Moderator: Cardiovascular Disease, Risk Factors and Diabetes
January 26, 2011
Dubai, UAE

Internatioanl Arab Health Cardiolovascular Conference
Moderator: Cardiac Imaging
January 27, 2011
Dubai, UAE

Update on Accreditation
SKMC
January 31, 2011
Abu Dhabi, UAE
55
SELECTED INVITED PRESENTATIONS

SKMC Leadership Development Day: Quality and Accreditation
Chairman
Hilton Hotel
February 13, 2011
Abu Dhabi, UAE

SKMC Medical Staff Meeting: Quality and Accreditation
March 7, 2011
Abu Dhabi, UAE

SKMC Medical Staff Meeting: Quality and Accreditation
March 30, 2011
Abu Dhabi, UAE

SKMC JCI Opening Conference and Hospital Overview
April 11, 2011
Abu Dhabi, UAE

SKMC JCI Data Use System Tracer
April 12, 2011
Abu Dhabi, UAE

Quality Standards and Accreditation in Healthcare 2011
Hospital Build
Chairman
June 13-15, 2011
Dubai, UAE

Workshop: Achieving Healthcare Quality and Safety through Accreditation
Chairman
June 15, 2011
Dubai, UAE

AHS Healthcare Quality Conference
Update on Patient Safety
October 22, 2011
Abu Dhabi, UAE

Atrial, Fibrillation In Gulf
November, 2011
Rome, Italy

Leadership Development Day
Quality Presentation
December 14, 2011
Abu Dhabi, UAE
56
SELECTED INVITED PRESENTATIONS



Third Annual SEHA Research Conference
Moderator
December 15, 2011
Abu Dhabi, UAE
Walk with the Doc
December 24, 2011
Abu Dhabi, UAE
Echocardiography Master Class Initiative
TEE of the Aorta
January 13, 2012
Abu Dhabi, UAE

Third Middle East
Quality Management in Healthcare Conference
Chairman
January 23-24, 2012
Dubai, UAE

Third Middle East Quality Management in Healthcare Conference
Opening Remarks by the Chair
January 23, 2012
Dubai, UAE

Third Middle East Quality Management in Healthcare Conference
Exploiting Challenges to Performance Improvement Agenda in the Region
January 23, 2012
Dubai, UAE

Third Middle East Quality Management in Healthcare Conference
Moderator: Practical Examples of Quality Improvement Activities
January 23, 2012
Dubai, UAE

Third Middle East Quality Management in Healthcare Conference
Opening Remarks by the Chair
January 24, 2012
Dubai, UAE

Third Middle East Quality Management in Healthcare Conference
Moderator: Key Concepts in Patient Safety
January 24, 2012
Dubai, UAE
57
SELECTED INVITED PRESENTATIONS

Drug Safety MENA Summit
Recognizing the Importance of Drug Safety and its Growing Prominence across the Middle
East
February 26-29, 2012
Dubai, UAE

Drug Safety MENA Summit
Recognizing the Importance of Drug Safety and its Growing Prominence across the Middle
East
Chairman
Exploring strategies to ensure medication safety
February 28, 2012
Dubai, UAE

Drug Safety MENA Summit
Recognizing the Importance of Drug Safety and its Growing Prominence across the Middle
East
Chairman's opening and closing remarks
Moderator
Exploring strategies to ensure medication safety
February 28, 2012
Dubai, UAE

Drug Safety MENA Summit
Post Conference Work-Shop
Urgency of Medication Reconciliation
Work-Shop Leader
February 29, 2012
Dubai, UAE

Culture of Safety
SKMC
March 29, 2012
Abu Dhabi, UAE

Beta Blockers in Hypertension
April 13, 2012
Kuwait, Kuwait

Heart Disease in Women
Chairman
May 4, 2012
Abu Dhabi, UAE

Cardiovascular Global Risk
Chairman
May 8, 2012
Abu Dhabi, UAE
58
SELECTED INVITED PRESENTATIONS

CEPHESUS Study
Strategies to Improve Goal Attainment
May 15, 2012
Dubai, UAE

Hypertension: Translating Evidence into Clinical Practice
May 2012
Abu Dhabi, UAE

Hospital Built
Chairman
June 4-5, 2012
Dubai, UAE

Hospital Built
Lean Six Sigma: SKMC Primary Angioplasty Door-To-Balloon Time
June 4-5, 2012
Dubai, UAE

Cardiovascular Prevention-Raised Expectations from Recent Outcome Trials: Are all ARBs
Equal
June17, 2012
Abu Dhabi, UAE

How to Effectively Screen and Identify our at Risk Patients in the PCP Setting: Which tools
and When
June17, 2012
Abu Dhabi, UAE

Lean Six Sigma Symposium
Chairman
June 20,2012
Abu Dhabi, UAE

Ambulatory Blood Pressure Monitoring Workshop
FMC Clinics
June 29, 2012
Abu Dhabi, UAE

Ambulatory Blood Pressure Monitoring
FMC Clinics
August, 2012
Abu Dhabi, UAE

Update on Systemic Hypertension
AHS Symposium
September 1, 2012
Abu Dhabi, UAE
59
SELECTED INVITED PRESENTATIONS

Safety Culture
September 2, 2012
Abu Dhabi, UAE

Lean Six Sigma: Door-to-Balloon PCI project
September 2, 2012
Abu Dhabi, UAE

Healthcare Management Workshop
Zayed University
September 15, 2012
Abu Dhabi, UAE

Center For Transforming Healthcare: International Hand Hygiene Pilot Project. Targeted
Solution Tool (TST)
JCI Meeting
September 25, 2012
Frankfurt, Germany

Leadership and Quality
September 30, 2012
Abu Dhabi, UAE

Center For Transforming Healthcare: International Hand Hygiene Pilot Project. Targeted
Solution Tool (TST)
JCI Executive Briefing
October 3, 2012
Dubai, UAE

Thrombosis Update
October 9, 2012
Abu Dhabi, UAE

Third Annual Cold Chain MENA
Chairman
October 15-18, 2012
Dubai, UAE

Third Annual Cold Chain MENA
Chairman
October 15-18, 2012
Dubai, UAE

Ambulatory Blood Pressure Monitoring Management
December 18, 2012
Abu Dhabi, UAE
60
SELECTED INVITED PRESENTATIONS

Cardiovascular prevetion in CV risk patients: Recent evidence and guideline updates
January 12, 2012
Istanbul, Turkey

Workshop: ACE's vs. ARB's-Evidence, safety and tolerability
January 12, 2012
Istanbul, Turkey

Arab Health Quality Management
Chairman
January 28-29, 2013
Dubai, UAE

Arab Health Quality Management
Lean and Six Sigma Methodology: Joint Commission Centre for Transforming Healthcare
Hand Washing Case Study
January 28-29, 2013
Dubai, UAE

Arab Health Quality Management
EFQM - The Journey to Excellence
January 28-29, 2013
Dubai, UAE

Arab Health Quality Management
Infection Prevention: CLABSI (Central Line Blood Stream infection)
January 28-29, 2013
Dubai, UAE

Arab Health Quality Management
Lean Six Sigma Primary Percutaneous Intervention: Door-to-balloon Time
January 28-29, 2013
Dubai, UAE

Sharing best practcices in implementing JCI standards
SKMC experience in selecting the clinical indicators
January 28-29, 2013
Dubai, UAE

Drug Safety MENA Summit
Organizing Committee
February 13, 2013
Yas Island, UAE
61
SELECTED INVITED PRESENTATIONS

Drug Safety MENA Summit
Developing Performance Improvement Activities to Improve Medication Safety
February 13, 2013
Yas Island, UAE

Drug Safety MENA Summit
Moderator
February 13, 2013
Yas Island, UAE

SKMC Experience in Selecting the Clinical Indicators
February19, 2013
Dubai, UAE

Contemporary Management of Acute Coronary Syndrome
Februray 24, 2013
Al Ain, UAE

An Integrated Therapeutic Approach for Glucose and Cholesterol Management in Patients
With Type 2 Diabetes
Februray 24, 2013
Abu Dhabi, UAE

Hypertension and Cardiovascualr Protection: What do the evidence tell us?
Februray 27, 2013
Zayed Military Hospital Cardiology Grand Round
Abu Dhabi, UAE

Patient Safety MOH Symposium
Role of lean Six Sigma in health care Quality & Patient Safety
March 7th, 2013
Dubai, UAE

First Abu Dhabi Cradiac and Vascular Disease Conference
Cradiovascular Disease: Quality Parameters
March 11, 2010
Abu Dhabi, UAE

Hypertenion Symposium: Combination Therapy
March 15, 2013
Dubai, UAE

Gulf Lipids Expert Forum Meeting
March 22, 2013
Dubai, UAE

MEA Thrombosis expert forum TEFO
March 22, 2013
Dubai, UAE
62
SELECTED INVITED PRESENTATIONS

2nd International Conference on "Vitamin D Deficiency and its Health Consequence
Moderator
March 22, 2013
Abu Dhabi

Towards Better Patient Management
Meeting Challenges of Cardiovascualr Disease
March 24, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
Scientific Advisory Committee
March 24-27, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
Scientific Advisory Committee: Abstract Reviewer
March 24-27, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
SKMC Study Tour Lead
March 24, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
Moderator: Leadership and Culture
March 25, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
Moderator: Leadership Management
March 25, 2013
Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013
Performance Improvement in Safety: Benefits of implementing Lean Six Sigma
March 26, 2013
Abu Dhabi, UAE

Lean Six Sigma
Outpatient pharmacy safety and waiting time
April 13-14, 2013
Dubai, UAE
63
SELECTED INVITED PRESENTATIONS


10th Hospital Design and Infrasctrutre Conference
Smart Design and Quality of Care: Safety and Risk Mangement in Hospital Design
June 4, 2013
Dubai, UAE
Fifth Middle East Health Quality Management Conference
Chairman
January 27-28, 2014
Dubai, UAE

Fifth Middle East Health Quality Management Conference
Lean, Six Sigma and Change Management in Healthcare
January 27, 2014
Dubai, UAE

Fifth Middle East Health Quality Management Conference
EFQM
January 27, 2014
Dubai, UAE

International Medical Travel Exibition and Conference
Debate Role of Quality
March 5th 2014
Dubai, UAE

MEIRC Conference
High Reliability in Healthcare
April 2, 2014
Abu Dhabi, UAE

Healthcare Supply Chain Strategies
Chairman
April 7th, 2014
Dubai, UAE

Healthcare Supply Chain Strategies
The Critical Stretegic Role Supply Chain plays In The Delivery of High Quality Care
April 7th, 2014
Dubai, UAE
64
SELECTED INVITED PRESENTATIONS

Abu Dhabi Quality Forum 2014
Building a Quality System in Healthcare
April 28, 2014
Abu Dhabi, UAE

Diabetes Mellitus Symposium
Cardiovascular Burden in Type 2 Diabetes Mellitus
May 2, 2014
Abu Dhabi, UAE

ACLS Course
Intsructor
May 12-13, 2014
Abu Dhabi , UAE

Key Note Speaker
Zayed University
Healthcare Management
May 24, 2014
Abu Dhabi, UAE

Regional Scientific Cardiovascular Exchange Forum
Challenging Questions in Hypertension
May 30, 2014
Istanbul, Turkey

MENA Pharmaceutical Cold Chain
Lean, Six Sigma and Change Management: Robust Performance Improvement- Tools to
create and sustain world-class healthcare cold chain
June 4, 2014
Dubai, UAE

Update on The Management of Dyslipidemia
New ACC guidelines
June 8, 2014
Abu Dhabi, UAE

ACLS Course
Intsructor
June 9-10, 2014
Abu Dhabi , UAE

6th Middle East Quality Management in Healthcare Conference
Chairperson
26-27 January 2015
Dubai, UAE
65
SELECTED INVITED PRESENTATIONS

GCC Pharmaceutical Congress
Managing the interface between phramacy and the hospital’s C-suite
September 14, 2014
Abu Dhabi, UAE

Cardiology Conference
Co-Chairperson
October 18, 2014
Abu Dhabi, UAE

Cardiology Conference
Update on Heart Failure
October 18, 2014
Abu Dhabi, UAE

Patient Safety
October 19, 2014
Abu Dhabi, UAE

Lean Six Sigma
October 20, 2014
Abu Dhabi, UAE

Dubai Healthcare Conference
High Reliability in Healthcare
October 23, 2014
Dubai, UAE

LDL, BP & Cardiovascular Disease- Critical Questions & The Evidence
October 29, 2014
Abu Dhabi, UAE

ACLS Provider Course
Lead Instructor
November 5-6, 2014
Abu Dhabi, UAE

IHI Symposium
Moderator
November 16, 2014
Dubai, UAE

Innovative Strategies for Improving Patient Care
Scientific Board
November 24-27, 2014
Abu Dhabi, UAE
66
SELECTED INVITED PRESENTATIONS

Innovative Strategies for Improving Patient Care
Scientific Board
November 24-27, 2014
Abu Dhabi, UAE

Innovative Strategies for Improving Patient Care
Lean Six Sigma in Healthcare Workshop
November 24, 2014
Abu Dhabi, UAE


Innovative Strategies for Improving Patient Care
Improving Quality and Patient Care through Innovative Leadership Strategies
November 25, 2014
Abu Dhabi, UAE

Public Speaking T raining
December 10, 2014
Dubai, UAE

Green Belt Lean Six Sigma Course
Chairperson
December 11-12, 2014
Dubai, UAE

6th Middle East Quality Management in Healthcare Conference
Chairman
January 26-27, 2015
Dubai, UAE

6th Middle East Quality Management in Healthcare Conference
CME Co-Director
January 26-27, 2015
Dubai, UAE

6th Middle East Quality Management in Healthcare Conference
Moderator
January 26-27, 2015
Dubai, UAE

6th Middle East Quality Management in Healthcare Conference
Gemba Walks: A management improvement process for healthcare leadership
January 26-27, 2015
Dubai, UAE

6th Middle East Quality Management in Healthcare Conference
Healthcare Kaizen: Sustainable Healthcare and Hospital Improvements
January 26-27, 2015
Dubai, UAE
67
SELECTED INVITED PRESENTATIONS

6th Middle East Quality Management in Healthcare Conference
Transforming Quality into Best Practice
January 26-27, 2015
Dubai, UAE

Preventive Healthcare Forum 2015
Keynote speaker
GCC region’s healthcare challenges on lifestyle related diseases
January 26, 2016
Dubai, UAE

Update on Hypertension
March 14, 2015
Abu Dhabi, UAE

Healthcare Supply Chain Strategies
Building a Lean, Efficient, Patient-Centric Healthcare Supply Chain
Chairman
April 19-22, 2015
Dubai, UAE

Middle East Forum on Quality and Safety in Helathcare
Institute for Helathcare Improvement
Success Stories from the Region
May 29-31, 2015
Doha, Qatar

Foundation in Patient Safety Training Program
Institute for Healthcare Improvement
Key Speaker
September 2-3, 2015

Patient Safety Conference
Chairman
October4-6, 2015
Dubai, UAE

Patient Safety Conference
Team Work and Crew Resource Management
October4-6, 2015
Dubai, UAE

Patient Safety Conference
Moderator
October4-6, 2015
Dubai, UAE
68
SELECTED INVITED PRESENTATIONS

Patient Safety Conference
Patient Safety Tools
October4-6, 2015
Dubai, UAE

Patient Safety Conference
Critical Drivers For Successful Leadership In Quality Improvement
Workshop Facilitator
October4-6, 2015
Dubai, UAE

Clinical Echocardiography
Echo in Heart Failure
October 10-12, 2015
Dubai, UAE

ASQ Regional Quality Conference
Chairman, Healthcare
November 4-5 2015
Dubai, UAE

ASQ Regional Quality Conference
Creating a Highly Reliable Health System
November 4-5 2015
Dubai, UAE

ASQ Regional Quality Conference
Change Management
November 4-5 2015
Dubai, UAE

ASQ Regional Quality Conference
Update on Innovation
November 4-5 2015
Dubai, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
Conference Chaiman
November 26-27, 2015
Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
Chaiman, Scientific Committee
November 26-27, 2015
Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
Chaiman, Organizing Committee
November 26-27, 2015
Abu Dhabi, UAE
69
SELECTED INVITED PRESENTATIONS

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
Update on Heart Failure Guidelines
November 26-27, 2015
Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
The Challenge of Heart Failure with Preserved Ejection Fraction
November 26-27, 2015
Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy
Reducing Heart Failure Readmission
November 26-27, 2015
Abu Dhabi, UAE

HIMS Middle East
Delighting Nurses through the consolidation of Clinically Relevant Information with SBAR
December 12, 2016
Abu Dhabi, UAE

CPHQ Review Course
Chairman
January 9-12, 2016
Abu Dhabi, UAE

6th Middle East Quality Management Conference
Chairman
January 27-28, 2016
Dubai, UAE

6th Middle East Quality Management Conference
The Future of Quality Management- Resilience Healthcare
January 27-28, 2016
Dubai, UAE

6th Middle East Quality Management Conference
Practical Implementation of Lean Six Sigma Methodologies in Hospitals
January 27-28, 2016
Dubai, UAE

6th Middle East Quality Management Conference
Innovation and Creativity in Healthcare
January 27-28, 2016
Dubai, UAE

SKMC ACLS
Course Instructor
February 8-9, 2016
Abu Dhabi, UAE
70
SELECTED INVITED PRESENTATIONS

Update on Anticoagulation
Chairman
March 11, 2016
Abu Dhabi, UAE

Role of Lean Six Sigma in Supply Chain
Baraha Hospital
March 13, 2016
Dubai, UAE

SKMC ACLS
Lead Instructor
April 4-5, 2016
Abu Dhabi, UAE

Update on Quality in SKMC
Quality Grand Round
Cleveland Clinic Main Campus
May 17, 2016
Cleveland, Ohio, USA
71
BIBLIOGRAPHY:
1. A.Om, S. Ellahham, G.DiSciascio: Cholesterol Embolism: An Underdiagnosed Clinical
Entity. Am Heart J 1992 Nov; 1 24(5): 1321-1326.
2. A.Om, S. Ellahham, G. W. Vetrovec: Radiation-induced Coronary Artery Disease. Am
Heart J 1992 Dec; 124(6): 1598-1602.
3. A.Om, S. Ellahham, G. DiSciascio: Management of Cocaine-Induced Complications. Am
Heart J 1993 Feb; 125 (Pt 1): 469-475.
4. A.Om, S. Ellaham, J. P. Ornato: Reversibility of Cocaine-Induced Cardiomyopathy.
Am Heart J 1992 Dec; 124: 1639-1641.
5. A.Om, S. Ellahham, J.P. Ornato, G.W. Vetrovec: Cocaine-Induced Complications:
Possible Relationship to Low Plasma Cholinesterase Enzyme. Am Heart J 1993 Apr; 125:
1114-1117.
6. A. Om, S. Ellahham, G.W. Vetrovec,C. Guard, S. Reese, J.V. Nixon: Risk of Left
Ventricular Hypertrophy in Normotensive Cocaine Users. Am Heart J 1993 May;
125:1441-1443.
7. Shiran A, Goldstein SA, Zafar S, Ellahham S, Sears-Rogan P, Pinnow E, Lindsay J Jr:
Determination of pretest probability for detection of a cardiovascular source of emboli by
transesophageal echocardiography using clinical and transthoracic echocardiographic data.
Am J Cardiol 1998;81:1506-1508.
8. Ran Kornowski, MD, Mun Hong, MD, Lior Gepstein,MD, Steven Goldstein, MD, Samer
Ellahham MD, Slomo A. Ben-Haim, MD, DSc, Martin Leon, MD. Preliminary Animal
and Clinical Experiences Using an Electro-Mechanical Endocardial Mapping Procedure to
Distinguish Infarcted from Healthy Myocardium. Circulation 1998 Sep 15; 98(II): 111624.
9. Avinoam Shiran, MD; Steven Goldstein, MD; Samer Ellahham, MD; Gary Mintz;
Augusto Pichard, MD; Ellen Pinnow, MS; Joseph Lindsay, MD. Accuracy of TwoDimensional Echocardiographic Planimetry of the Mitral Valve Area Before and after
Balloon Valvuloplasty. Cardiology 1998:90:227-230.
10. Bruce M. Smith, Samer Ellahham, Jon A. Satnford, Debra Kohlman Trigoboff, Maria T,
Tupas-Habib, Hector Molina, Jedan Philips. Flow-Mediated Dilation in lower extremity
vein grafts. Vascular Surgery 1999:33:595-602.
11. FuchsS, KornowskiR, Shiran A, Pierre A, Ellahham S., Leon MB., Electromechanical
Chracterization of myocardial hibernation in a pig model. Coronary Artery Disease1999,
10 (3): 195-8.
72
BIBLIOGRAPHY:
12. Samer Ellahham. Bosentan and the Endothelin System in Congestive Heart Failure.
Pharmacy Update.National Institue of Health 1999, January/February.
13. FuchsS, KornowskiR, Shiran A, Pierre A, Ellahham S., Leon MB. Electromechanical
Chracterization of myocardial hibernation in a pig model. Coronary Artery Disease 1999,
10 (3): 195-8.
14. Baha Fadel, Samer Ellahham, MD; Matthew D. Ringel, MD; Joseph Lindsay, Jr., MD;
Leonard Wartofsky, MD; and Kenneth Burman, MD. Hyperthyroidism and Heart. Clinical
Cardiology. Clin Cardiol June 2000, 23(6):402-8.
15. Samer Ellahham, Eva
Enhances Pulmonary Vein Flow Velocity Signals: A Multicenter Study. Clinical
Cardiology 2000, 23 (2): 91-95.
16. Abriham Prasad, Theresa Tupas-Habib, William H. Schenke, Rita Mincemoyer, Panza
JA,Waclawin MA, Samer Ellahham, Arshed A. Quyyumi. Acute and chronic angiotensin
type1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation
2000, 101(20):2349-54.
17. Samer Ellahham, Vincent Charlon, Zaid Abbasi, Karim A. Calis, Wassim Choucair.
Bosentan and the endothelin system in congestive heart failure. Clinical Cardiology; 2000
(11):803-7.
18. Peter F. Kokkinos, Wassim Choucair, Page Graves, Vasilios Papademetriou, Samer
Ellahham. Chronic Heart Failure and Exercise Training. American Heart Journal
2000,Volume 140 (1): 21-28.
19. Minna L. Hannuksela, MD and Samer Ellahham, MD. Benefits and Risks of Sauna
Bathing. American Journal of Medicine, 2001, Volume 110(2):118-126.
20. Shiran, Avinoam ; Goldstein, Steven A.; Ellahham, Samer ; Leon, Martin B. ;
Kornowski, Ran.Immediate effect of Biosense guided percutaneous direct myocardial
revascularization with holmium:yttrium aluminium garnet laser on myocardial
contractility assessed by transesophageal echocardiography. Coronary Artery Disease June
2000, 11(4):359-361.
21. Zaid A. Abassi, Joseph Winaver, Samer Ellahham, Aaron Hoffman. The Intrarenal
Endothelin System and Hypertension. News In Physiological Sciences, 2001. Volume 16:
152-156.
22. Ran Kornowski, Shmuel Fuchs, Avinoam Shiran, Natama Summers, Matthew
Pietrusewicz, SamerEllahham, Steven A.Goldstein, MartinB.Leon. Catheter-based
electromechanical mapping to assess regional myocardial function: A comparative
analysis with transthoracic echocardiography. Catheter Cardiovasc Interv. Mar
2001;52(3):342-7.
73
BIBLIOGRAPHY:
23. Arvind K. Sharma, Shadi M. Hamwi, Nidhi Garg, Marco T. Castagna. William Suddath,
Samer Ellahham, Joseph Lindsay. Percutaneous Interventions in Patients With CocaineAssociated Myocardial Infarction: A Case Series and Review. Catheterizartion and
Cardiovascular Interventions 2002, Volume 56: 346-352.
24. Julian P.J. Halcox, KhaledR.A.Nour, Gloria Zalos, Rita Mincemoyer, Myron A.
Waclawiw, Candido Rivera, Georgia Willie, Samer Ellahham,Arshed A. Quyyumi. The
effect of sildenafil on human vascular function, platelet activation and myocardial
ischemia. JAm Coll Cardiol.2002 , Oct 2;40(7):1232-40.
25. Saleet Jafri, Malda Bashi, Samer Ellahham: Usefulness of Lercanidipine, a new
Calcium antagonist, for systemic hypertension. Opinion Article: Hypertension Today,
November, 2003.
26. Samer Ellahham, MD, Yasmin Said, Phd, Edward Wegman, Phd. The Endocannabinoid
System. A novel Approach to Cardiovascualr Risk Reduction. To be submitted to
American Journal of Cardiology in 2008.
27. Anthony L. McCall, Samer Ellahham: What are the Potential Clinical Benefits of
Insulin Therapy in Treating the Critically Ill?. Submitted to Clinical Cardiology.
28. Samer Ellahham, MD, Peter M. Mathisen, PhD, Chadi Ibrahim, MD:Intensive
InsulinTherapy after Acute Stroke in Patients with Type 2 Diabetes. Submitted to Vascualr
Medicine.
29. Samer Ellahham, MD. Role of Antiplatelet Agents in the Prevention of
Atherothrombotic Events in High-risk Patients. Southern Medical Journal,
101(3):273-283, March 2008.
30. Samer Ellahham, MD, Gregory Trachiotis, MD, Judd Hollander, Kirk Garratt: A Safety
Review of all Antiplatet Agents: Current and Future Agents. Submitted to The Journal of
Emergency Medicine.
31. Anthony L. McCall, MD, PhD, Samer Ellahham, MD: Clinical benefits of insulin
therapy in critically ill patients. Submitted to Clinical Cardiology 2008.
32. Peter M. Mathisen, PhD, Samer Ellahham, MD, Chadi Ibrahim, MD:Intensive Insulin
Therapy after Acute Stroke in Patients with Type 2 Diabetes. Accepted Vascular
Medicine Journal 2008.
33. Samer Ellahham, MD, Helmy Siragy: Suppression of the Renin-Angiotensin-Aldosterone
System in Systemic Hypertension: Choice of Agents and Clinical Impact. Accepted in
comprehensive online, continuing medical education (eCME) site –Cyberounds 2008.
34. Anthony L. McCall, MD, PhD, Samer Ellahham, MD: Molecular Mechanisms of
Hyperglycemia in Critically Ill Patients: Rationale for the Clinical Benefits of Insulin
Therapy.
34. Samer Ellahham, MD, Gregory Trachiotis, MD; Judd E. Hollander, MD; Kirk Garratt,
MD: A Delicate Balance: Assessing the Safety of Upstream Initiation of Antiplatelet
Therapy. Journal of Emergency Medicine.
74
BIBLIOGRAPHY:
35. Samer Ellahham, MD: Evolving Management Options For Hypertension: Risk
Stratification, Various Populations and Special Situations in Middle East Asia 2010.
36. Samer Ellahham, MD: Cardiovascular Risk Assessment in the Patient with Diabetes: A
Quick Reference Guide.
37. Samer Ellahham,MD: Insulin therapy in critically ill patients. Vascular Health
and Risk Management, Nov 30, 2010.
38. Nicholas Turin, PhD, Samer Ellahham, MD: Venous Thromboembolism Prevention.
Arab Health Journal, 2010.
39. Samer Ellahham, MD. "Molecular Mechanisms of Hyperglycemia and CardiovascularRelated Events in Critically Ill Patients: Rationale for the Clinical Benefits of Insulin
Therapy", Vascular Health and Risk Management, Nov 30, 2010.
40. Samer Ellahham, Samir Aljabbari, Tristan Mananghaya, Salama raji, Abdulmajeed
Zubaidi: Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction
In Primary Percutaneous Intervention: Transformation using Robust Performance
Improvement BMJ Qual Improv Report 2015;4: doi:10.1136
41. Honeymol John, Abdelrahman Nimeri, Samer Ellahham: Improved Surgical Site Infection
(SSI) rate through accurately assessed surgical wounds. BMJ Qual Improv
Report 2015;4: doi:10.1136.
42. Honeymol John, Abdelrahman Nimeri, Samer Ellahham: Improved Surgical Site Infection
Paper accepted The ASHRM Annual Conference Committee (“Improving Mortality
Reviews - A Four Year Journey in the Middle East.”) presented as Oral presentation and
Abstract in Indiana, USA.
43. Haytham Taha, Salama J. Raji, Samer Ellahham, Nihal Bashir, Manar Al hanaee, Hessa
Boharoon, , May AlFalahi. Improving venous thromboembolism risk assessment
compliance using the electronic tool in admitted medical patients BMJ Quality Journal
October 2015.
44. Ala'a Abuhejleh, Mohammed Dulaimi, Samer Ellahham. Using Lean management to
leverage innovation in healthcare projects: case study of a public hospital in the UAE. BMJ
Innov 2016;2:22-32.
45. Ala'a Abuhejleh, Mohammed Dulaimi, Samer Ellahham. Le Using Lean management to
leverage innovation in healthcare projects: case study of a public hospital in U.A.E.
International Journal of Advanced Research (2016), Volume 4, Issue 5, 896-898.
75
BIBLIOGRAPHY:
46. Ala'a Abuhejleh, Paul Gardiner, Mohammed Dulaimi, Samer Ellahham. Exploring the role
of Lean methodology as a tool for performance improvement in healthcare projects: an
ethnographic case study in U.A.E. Submitted.
47. Haytham Taha, D, dana abdulhay, Neama Luqman, Samer Ellahham. Improving admission
medication reconciliation compliance using the electronic tool in admitted medical patients. BMJ
Qual Improv Report 2016;5: doi:10.1136/bmjquality.u209593.w4322.
76
ABSTRACTS:
1. S. Ellahham, K. Nelson, MT. Schlutz, LF. Fox, JS. Hanrahan, MR. Taylor, DA. Julius,
PK. Mohanty: Sleep-Disordered Breathing is Common in Cardiac Transplant Recipients
(Presented at the First Annual Fellows' Conference on Transplantation, Chicago, 1991).
2. S. Ellahham, K. Nelson, MT. Schlutz, LF. Fox, JS. Hanrahan, MR. Taylor, DA Julius, PK.
Mohanty: Sleep Apnea is Common in Cardiac Transplant Recipients (Presented at the 12th
Annual Scientific Session of the International Society of Heart and Lung Transplantation,
1992).
3. S. Ellahham, K. Nelson, MT. Schlutz, JS. Hanrahan, A. Om, LF. Fox, MR. Taylor, DA.
Julius, PK. Mohanty: Sleep-Disordered Breathing is Common in Cardiac Transplant
Recipients (Oral presentation at the American College of Chest Physicians Meeting, 58 th
Annual Scientific Session, Alfred Soffer Research Award, 1992).
4. S. Ellahham, K. Nelson, MT. Schlutz, JS Hanrahan, A. Om, LF. Fox, MR. Taylor, DA
Julius, A. Guerraty, PK. Mohanty: Blood Pressure and its Variability Following Human
Heart Transplantation: Effect of Sleep and Sleep-Disordered Breathing (Oral presentation
at the American College of Chest Physicians Meeting, 58th Annual Scientific Session,
1992).
5. A. Om, S. Ellahham, JP. Ornato, GW. Vetrovec, C. Guard, S. Reese, JV. Nixon: Risk of
Left Ventricular Hypertrophy in Normotensive Cocaine Users (Poster Presentation at the
American College of Chest Physicians eeting, 58th Annual Scientific Session, 1992).
6. A. Om, JV. Nixon, JP. Ornato, S. Ellahham, G.W. Vetrovec: Echocardiographic
Evaluation of Valvular Predisposition for Endocarditis in Cocaine Users (Oral Presentation
at the American College of Chest Physicians Meeting, 58th Annual Scientific Session,
1992).
7. S. Bajaj, VA. Luketic, ML. Shiffman, AJ. Sanyal, PP. Purdum, RA. Fisher, KB Brown,
MC. Posner, R. Kohli, GW. Vetrovec, R. Reddy, S. Ellahham, JL. Tatum: Efficacy and
Safety of Persantine Thallium Scanning (P-Thal) in the Evaluation of Patients Undergoing
Orthotopic Liver Transplantation (OLT); (Poster Presentation at the American College of
Chest Physicians Meeting, 58th Annual Scientific Session, 1992).
8. S. Bajaj, C. Crandall, H. Ibrahim, G. Vetrovec, G. DiSciascio, S. Ellahham, D. Salter, A.
Gueratty, PK. Mohanty: Clinical Significance of Coronary Collateral Circulation in
Cardiac Transplant Recipients (Poster Presentation at the American Heart Association
Meeting, 65th Annual Scientific Session, 1992).
9. A. Om, S. Ellahham, JP. Ornato, GW. Vetrovec: Cocaine-Induced Complications:
Possible Relationship to Low Plasma Cholinesterase Enzyme (American College of
Cardiology Meeting, 42nd Annual Scientific Session, 1993).
77
10. A. Om, S. Ellahham, R. Reddy, S. Bajaj, D. Romhilt, R. Quint, JL. Tatum:
Underestimation of Extent of Coronary Artery Disease on Dipyridamole Thallium
Tomographic Scintigraphy in the Presence of ST Segment Depression (International
Conference on Nuclear Cardiology, France, April 1993).
78
ABSTRACTS:
11. S. Bajaj, C. Crandall, G. DiSciascio, J. Tatum, S. Ellahham, H. Ibrahim, A. Guerraty, G.
Vetrovec, D. Salter, PK. Mohanty: Characterization of Coronary Collateral Circulation in
Cardiac Transplant Recipients (XVth Congress of The European Society of Cardiology,
1993).
12. A. Shiran, S. A. Goldstein, S. Ellahham, P. Sears-Rogan, E. Pinnow, J. Lindsay, Jr.. TEE
for Cardiovascular Source of Emboli: Determination of Pretest Probability Using TTE and
Presence of Atrial Fibrillation . JACC: Volume 29/ Number 2 (Supplement A),526 A,
February 1997.
13. Samer Ellahham, Mihaela Tebeica, Steven Goldstein, Augusto Pichard, Joseph Lindsay.
Safety of transesophageal-guided balloon mitral valvuloplasty in patients with atrial
thrombi (Research award and poster presentation, American College of Physicians, District
of Columbia Meeting, 1997).
14. Samer Ellahham, Mihaela Tebeica , Steven Goldstein, Augusto Pichard, Joseph Lindsay.
Transesophageal Echocardiographically - Guided Balloon Mitral Valvuloplasty is Safe in
Selected Patients with Left Atrial Thrombi (Poster Presentation, American Society of
Echocardiography Meeting, June,1997).
15. Mihaela Tebeica, Samer Ellahham, Ellen Pinnow, Joseph Lindsay, Steven Goldstein,
Augusto Pichard. Echo Score For Balloon Mitral Valvuloplasty Needs To Be Reevaluated.
(Poster Presentation, American Society of Echocardiography Meeting, June,1997).
16. Jorge Cheirif, Douglas Segar, Eva Hausner, David Bach, Samer Ellahham, Miguel
Zabalgoitia. FS069 Greatly Improves the Diagnostic Utility of Ultrasound for Left
Ventricular Function. (Poster Presentation, American Society of Echocardiography
Meeting, June,1997).
17. M.Karl, S. Ellahham, R. Oskoui, L. Wartofsky, and K.D. Burman. Thyrotoxicosis
Associated with Rapidly Reversible Low-Output Heart Failure and Dilated
Cardiomyopathy (Poster Presentation, 79th Annual Meeting of The Endocrine
Society, June 1997).
18. A. Shiran, MD; S .Ellahham, MD; E. Pinnow, MS; A. Pichard, MD;J. Lindsay Jr., MD;
SA Goldstein, MD. Accuracy of planimetry for assessment of mitral valve area after
balloon valvulotomy (Poster Presentation, 63rd Annual International Scientific Assembly of
the American College of Chest Physicians, October 1997).
19. Mihaela Tebeica, Joseph Lindsay Jr, Ellen Pinnow, Samer Ellahham, Steven Goldstein,
Augusto Pichard. Echocardiographic Score For Mitral Balloon Valvuloplasty Needs To Be
Reevaluated (Poster Presentation, 70th Scientific Sessions of The American Heart
Association, November1997).
20. Momina Mastoor, Yvonne Bonnet, Ellen Pinnow, Samer Ellahham, Joseph Lindsay Jr.,
Augusto Pichard. New Devise Angioplasty: Gender Differences and Relation to Outcome.
47th Annual ACC Meeting, Atlanta, Georgia, March 1998.
79
ABSTRACTS:
21. Momina Mastoor, Samer Ellahham. A rare combination of anti-phospholipid antibody and
factor V mutation. American College of Physicians, Washington DC, May 1998.
22. Momina Mastoor, Samer Ellahham. Pitfalls in echocardiography-A case of a hiatal hernia
mimicking an extracardiac mass. American College of Physicians, Washington DC, May
1998.
23. Samer Ellahham, MD, Joseph Lindsay, MD. Safety of Arbutamine Stress Imaging in
Patients > 70 years. Poster presentation, American Society of Echocardiography Meeting,
San Francisco, June 1998.
24. Abhiram Prasad, Suresh Narayanan, Rita Mincemoyer, National Institute of Health,
Bethesda, MD, Theresa Tupas-Habib, Samer Ellahham, Washington Hospital Center,
Washington DC; Arshed A.Quyyumi, National Institute of Health, Bethesda, MD. Acute
and Long Term Effects of Angiotensin Type I Receptor Inhibition on Endothelial
Dysfunction in Atherosclerosis. Oral presentation, 71st Scientific Sessions, American Heart
Association Meeting, Dallas, Texas, November 11, 1998.
25. Samuel Fuchs, Ran Komowski, Avinoam Shiran, Samer Ellahham, Anthony Pierre, Mun
K. Hong, Martin B Leon, Washington Hospital Center, Washington, DC.
Electromechanical Characterization of Chronic Experimental Myocardial Ischemia in a Pig
Model. JACC, February 1999.
26. Samer Ellahham, Wassim Choucair, Ellen Pinnow, Augusto Pichard, Joseph Lindasy. Is
Echo Score the Best Predictor of Successful Transcatheter Balloon Mitral Valvuloplasty?
Washington Hospital Center, Washington DC. American Society of Echocardiography,
10th Annual Scientific Sessions, June 1998.
27. Bruce M. Smith, Samer Ellahham, Jon A. Satnford, Debra Kohlman Trigoboff, Maria
Tupas-Habib, Hector Molina, Jedan Philips. Flow-Mediated Dilation in lower extremity
vein grafts. Society for Clinical Vascular Surgery, 27th Annual Symposium on Vascular
surgery, Lake Buena Vista, Florida, 1999 .
28. Samer Ellahham, Theresa Tupas-Habib, Abhiram Prasad, Suresh Nara Yana, Rita
Mincemoyer, Arshed A. Quyymi. Acute and Long Term Effects of Angiotensin Type I
Receptor Inhibition on Endothelial Dysfunction in Atherosclerosis. NAAMA 16th
International Convention, Beirut, Lebanon, July 1999.
29. Samer Ellahham, Mihaela Tebeica , Steven Goldstein, Augusto Pichard, Joseph Lindsay.
Transesophageal Echocardiographically - Guided Balloon Mitral Valvuloplasty is Safe in
Selected Patients with Left Atrial Thrombi . Oral Presentation, NAAMA 16th International
Medical Convention, Beirut, Lebanon , July 1999.
30. Samer Ellahham, Avionam Shiran, Pamela Sears-Rogan, Joseph Lindsay Jr.,Steven
Goldstein, Martin Leon, Ran Kornowski. Catheter-Based Direct Laser Myocardial
Revascularization Using the Biosense TM System Preserves LV Function and Improves
Diastolic Function and Ischemic Mitral Insufficiency. Eleventh Annual Transcatheter
Cardiovascular Therapeutics Symposium, Washington DC, September 1999.
80
ABSTRACTS:
31. Samer Ellahham, Avionam Shiran, Steven Goldstein, Martin Leon, Ran Kornowski
Kornowski. Immediate Effect of Percutaneous Direct Myocardial revascularization With
Holmium: YAG Laser on Myocardial Contractility Assessed by Transesophageal
Transesopahgeal Echocardiogarphy. Eleventh Annual Transcatheter Cardiovascular
Therapeutics Symposium, Washington, DC, September 1999.
32. Avionam Shiran, Steven A. Goldstein, Wassim Choucair, Samer Ellahham. Immediate
Effect of Percutaneous Direct Myocardial Revascularization With Holmium: YAG Laser
on Myocardial Contractility Assessed by Transesopahgeal Echocardiogarphy. 72nd
Scientific Sessions of the American Heart Association, Atlanta, Georgia, November 7-10,
1999.
33. Gabriel Adelmann, Neil Weissman, Lameh Fananapazir, Samer Ellahham, Zuyue Wang,
Bernadette Falcon, Ellen Pinow, Kenneth Kent, Steven Goldstein. Early Dynamic Changes
in Subaortic Pressure Gradients After Successful Alcohol Septal Ablation in Patients with
Hypertertrophic Obstructive Cardiomyopathy. 12th Annual ASE Scientific Sessions,
Washington, Seattle, June 2001.
34. Joost Bottenbley, Yasmin H. Said, Edward Wegman, Samer Ellahham and David
Anderson: Relationship between Competitiveness of Colleges and Levels of Tobacco use,
Joint Statistical Meetings, Salt Lake City, UT, July 29-August 2, 2007.
35. Health benefits and Economic Impact, Joost Bottenblehy and Samer Ellahham and
Yasmin H. Said and Edward Wegman and Malda Bashi: Restriction of Trans Fatty Acids
in Washington, DC Metropolitan Area, Joint Statistical Meetings, Salt Lake City, UT , July
29-August 2, 2007.
36. Samer Ellahham, Yasmin H. Said, Edward Wegman, and Rima Allaham: Effect of
Intravenous Insulin Infusion on Coronary Artery Disease Joint Statistical Meetings, Salt
Lake City, UT, July 29-August 2, 2007.
37. Samer Ellahham, Yasmin H. Said, Edward Wegman: Update on Cardiometabolic Risk
Reduction: Role of the Endocannabinoid System, Joint Statistical Meetings, Salt Lake City,
UT, July 29-August 2, 2007.
38. Anan Said, Yasmin H. Said, Samer Ellahham, Edward Wegman, David Anderson, and
Joost Bottenbley: Tobacco Use and College Competitiveness: Assessing an Underlying
Correlation, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May
2007.
39. Effectiveness of an Endocannabinoid Antagonist in Reducing Cardiometabolic Risk,
Samer Ellahham, Anan Said, Yasmin H. Said, and Edward Wegman, Computing Science
and Statistics, Interface 2007, Philadelphia, PA, May 2007.
40. The Potential Health Benefits and Economic Impact on the Region, Anan Said, Samer
Ellahham, Yasmin H. Said, Malda Bashi, Edward Wegman, and Joost Bottenblehy
Banning Trans Fatty Acids in the Washington, DC Metropolitan Area: Computing Science
and Statistics, Interface 2007, Philadelphia, PA, May 2007.
81
ABSTRACTS:
41. New Insights into Intravenous Insulin Infusion on Coronary Artery Disease, Samer
Ellahham, Anan Said, Yasmin H. Said, Rima Allaham, and Edward Wegman, Computing
Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.
42. Antiplatelet agents in the prevention of atherothrombotic events, Samer Ellahham,
Yasmin H. Said, Edward J. Wegman, Rima Allaham, and Malda Bashi, Computing
Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.
43. Effect of Intravenous Insulin Infusion on Coronary Artery Disease, Samer Ellahham,
Yasmin H. Said, Edward J. Wegman, Malda Bashi, and Rima Allaham, Computing
Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.
44. Diabetes Mellitus and Obesity, Samer Ellahham, Yasmin H. Said, Edward J. Wegman,
Malda Bashi, and Rima Allaham, Computing Science and Statistics, Interface 2007,
Philadelphia, PA, May 2007.
45. Antiplatelet Agents in Acute Coronary Syndromes, Samer Ellahham, Rima Allaham,
Yasmin H. Said, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics,
Interface 2007, Philadelphia, PA, May 2007.
46. Peripheral Arterial Disease and Diabetes Mellitus, Samer Ellahham, Rima Allaham,
Yasmin H. Said, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics,
Interface 2007, Philadelphia, PA, May 2007.
47. Primary and Secondary Stroke Prevention, Samer Ellahham, Yasmin H. Said, Rima
Allaham, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics,
Interface 2007, Philadelphia, PA, May 2007.
48. New Hyperglycemia Increases Hospital Morbidity and Mortality, Samer Ellahham,
Yasmin H. Said, Rima Allaham, Edward J. Wegman, and Malda Bashi, Computing
Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.
49. Update on Cardiometabolic Risk Reduction: Role of the Endocannabinoid System, Samer
Ellahham, Yasmin H. Said, and Edward Wegman, Computing Science and Statistics,
Interface 2007, Philadelphia, PA, May 2007.
50. Insulin Infusion Therapy In Type 2 Diabetics Who Have Had An Acute Stroke, Chadi
Ibrahim, and Samer Ellahham, Yasmin H. Said, and Edward Wegman, Computing
Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.
51. Statistics of Peripheral Arterial Disease, Samer Ellahham, Malda Bashi, Yasmin Said,
Edward Wegman, and Rima Allaham, Computing Science and Statistics, Interface 2007,
Philadelphia, PA, May 2007.
52. Statistics of Women and Heart Disease in United States, Samer Ellahham, Rima Allaham,
Yasmin Said, Edward Wegman, Malda Bashi, Computing Science and Statistics, Interface
2007, Philadelphia, PA, May 2007.
82
ABSTRACTS:
53. The Health Benefits and Economic Impact of Restricting of Trans Fatty Acids: A Case
Study in the Washington, DC Metropolitan Area, Yasmin H. Said, Edward J. Wegman, and
Samer Ellahham, International Symposium on Business and Industrial Statistics 2007,
University of Azores, Sao Miguel Island, Ponta Delgada, Azores, Portugal, August 18-20.
54. Pulmonary Artery Hypoplasia, Pulmonary Hypertension and Hypospadias in a 22 year-old
male: H. Vincent Lawson MD and Samer Ellahham. ACP Convention, Washington DC
November, 2007.
55. Outcomes of Bariatric Surgery at BMI Abu Dhabi compared to ACS NSQIP Bariatric
Surgery Programs Awadelkarim Mohamed MD1, Eelaf El Hassan MD,, Karen McKenna
RN, Mohammed Al Hadad MD3, Michel Bussieres MD3, Samer Ellahham MD, Wayne
Wasden, Nicolas Turrin PhD, Nidal Dehni MD, Abdelrahman Nimeri MD.
56. Cohort & Outcomes of Bariatric Surgery at BMI Abu Dhabi compared to ACS NSQIP
Bariatric Surgery Programs Abdelrahman Nimeri MD, Karen McKenna RN, , Mohammed
Al Hadad MD, Michel Bussieres MD, Samer Ellahham MD, Wayne Wasden, Nicolas
Turrin PhD, Nidal Dehni MD.
57. Cohort & Outcomes of Sheikh Khalifa Medical City (SKMC) compared to ACS NSQIP
Hospitals Abdelrahman Nimeri, MD, Karen McKenna RN, Nidal Dehni MD, Michel
Bussieres MD, Samer Ellahham MD, Mohammed Al Hadad MD, Wayne Wasden CPHQ,
Nicolas Turrin PhD.
83
CONTRIBUTOR TO PUBLICATIONS
1. Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in
patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol
levels. The American Journal of Cardiology, Volume 91, Issue 11, Pages 1304-1310.
2. Improved left ventricular endocardial border delineation and opacification with OPTISON
(FS069), a new echocardiographic contrast agent. J Am Coll Cardiol, 1998; 32:746-752.
3. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
Hypertension; 2001; 37:12.
4. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction
in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, Volume
359, Issue 9311, Pages 995-1003.
5. Rationale and Design of a Secondary Prevention Trial of Antibiotic Use in Patients after
Myocardial Infarction: The WIZARD (Weekly Intervention with Zithromax
[Azithromycin] for Atherosclerosis and Its Related Disorders) Trial. The Journal of
Infectious Diseases, volume 181 (2000), pages S572–S578.
6. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based
on valsartan or amlodipine: the VALUE randomised trial. The Lancet, Volume 363, Issue
9426, Pages 2022-2031.
7. Characteristics of 9194 Patients with Left Ventricular Hypertrophy: The LIFE Study.
Hypertension. 1998; 32:989-997.
BOOKS:
1. Jamie’s Heart. A coloring book for children dealing with simple preventive measures.
Published in 2002.
2. Quality And Patient Safety at Sheikh Khalifa Medical City 2010. Published in 2011.
3. PATIENTS FISRT: QUALITY OUTCOMES SHEIKH KHALIFA MEDICAL
CITY 2012. Published in 2013.
4. PATIENTS FISRT: QUALITY OUTCOMES SHEIKH KHALIFA MEDICAL
CITY 2013. Published in 2015.
84
CARDIOVASCULAR RESEARCH:
Principal Investigator: A Multicenter, Multinational Study to evaluate the clinical utility and
safety of the GenESA system to diagnose coronary artery disease in patients with known or
suspected coronary artery disease.
Principal Investigator: A Comparative Study for the Clinical Evaluation of the Safety and
Efficacy of Intravenously Administered FS069 vs. Albunex for Endocardial Border
Delineating, Left Ventricular Opacification, and D Doppler Signal Enhancement.
Principal Investigator: LIFE (Losartan Intervention For Endpoint reduction in
hypertension). A triple-blind, parallel study to investigate the effect of losartan
versus atenolol on the reduction of morbidity and mortality in hypertensive
patients with left ventricular hypertrophy.
Principal Investigator : LIFE - ECG sub-study.
Principal Investigator : LIFE - Quality of life sub-study.
Principal Investigator: CONVINCE (Controlled ONset Verapamil Investigation
Cardiovascular Endpoints). A ong-term prospective trial to determine whether a regimen
starting with verapamil with a novel delivery system is at least as effective as a regimen
starting with the choice of first-line "standardof care" (diuretic or beta blocker-as recommended
by the Fifth Joint National Committee [JNC-V] on Detection, Evaluation, and Treatment of
High Blood Pressure) in reducing the occurrence of fatal cardiovascular disease, Nonfatal
stroke or nonfatal myocardial infarction in patients with primary hypertension followed over a
four-to-six-year period.
Principal Investigator: A comparison of efficacy and safety of Mibefradil with
patients with mild to moderate hypertension.
Losartan in
Principal Investigator: A multicenter pilot study of expanded utilization of
intravenous
beta-blocker therapy in acute ischemic syndromes: The Esmolol
Myocardial Ischemia
Trial (EMIT).
Principal Investigator: Aggressive Diagnosis of Restenosis: The ADORE Study.
Principal Investigator: The WIZARD Trial: A randomized, double-blind,
placebo
controlled trial of the effect weekly azithromycin on the indicence of
coronary artery disease
in subjects with evidence of exposure to c. pneumoniae.
Principal Investigator: Routine versus Selective Exercise Treadmill Testing fter Angioplasty:
The ROSETTA Observational Study.
Principal Investigator: Inhibition of MetalloProtease in a Randomized Exercise and
Symptoms Study in Heart Failure: The IMPRESS Trial.
85
CARDIOVASCULAR RESEARCH:
Principal Investigator: VALUE- A prospective, multinational, multicenter, double-blind,
randomized, active-controlled trial in patients with essential hypertension to compare the effect
of Valsartan 80 and 160 mg, with or without the addition of hydrochlorothiazide, once daily to
that of amlodipine 5 and 10 mg once daily, with or without the addition of hydrochlorothiazide,
on cardiovascular morbidity and mortality.
Principal Investigaror: CURE - Clopidogrel in Unstable Angina to prevent Recurrent
Ischemic Events.
Principle Investigator: CAMELOT- Comparison of Amlodipine versus Enalapril to Limit
Occurences of thrombosis.
Principle Investigator: SYMPHONY II- A Phase III, Multicenter, International,
Randomized, Double- Blind, Aspirin-controlled Trial to Evaluate the Efficacy and Safety of
two regimens with Xubix (Sibrafiban;Ro 48-3657), an Oral Platelet Glycoprotein Iib/IIIa
Receptor Antagonist, as Therapy for the Long Term Prevention of secondary Vascular Events
in Patients after an Acute Coronary Syndrome.
Principle Investigator: A Multicenter, Randomized, Double - Blind, Lisinopril and Placebo
Controlled Trial of The Antihypertensive Efficacy and safety of Omapatrilat in Black Subjects
with Mild to Moderate Hypertension.
Principle Investigator: A Randomized, Double - Blind, Placebo-Controlled, Concentration
Escalating, crossover Study of BG9719 alone and in combination with Furosemide in Subjects
with Moderate to Severe Congestive Heart Failure and mild to Moderate Renal Insufficiency.
Principle Investigator: A 12 week Randomized Double-blind Placebo-controlled Multicenter
trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg) and Atorvastatin 10mg) in
the Treatment of Subjects with hypercholesterolemia.
Principle Investigator: MOXCON SR Moxonidine for Congestive Heart Failure The Effect
of Sustained Release Moxonidine on Mortality and Morbidity in Patients with Congestive
Heart Failure.
Principle Investigator: ENABLE-2 - Endothelin Antagonist Bosentan for Lowering cardiac
Events in heart failure. A Double-Blind, Randomized, Placebo-controlled Study to Assess the
Effects of R0 47-0203 (bosentan) on the Morbidity and mortality of patients with Chronic
Heart Failure.
Principle Investigator: OVERTURE – Omapatrilat versus Enalapril Randomized Trial of
Utility in Reducing Events. A Double-Blind, Randomized, Multinational Trial Comparing The
Effects of Treatment with the Vasopepetidase Omapatrilat or the ACE inhibitor Enalapril on
Major clinical Evants in Patients With heart failure.
Principle Investigator: A 24-Week Randomized Multicenter Trial to Evaluate the Efficacy
and Safety of ZD4522 and Niaspan Monotherapy, as Well as Selected Combinations of
ZD4522 and Niaspan, in the Treatement of Subjects With Type IIb orIV Hyperlipidemia.
86
CARDIOVASCULAR RESEARCH:
Co-Investigator: Estrogen Status and Arrhythmias in Women..
Co-investigator:The The NOGA SYSTEM to detect chronic myocardial
ischemia and to perform percutaneous myocardial revascularization, a pig instent restenosis model.
Co Investigator: The The NOGA SYSTEM to detect chronic myocardial
ischemia and to perform percutaneous myocardial revascularization, a pig instent restenosis model.
Co-Investigator: Treatment of Patients with Non Thyroidal Illness.
Co-investigator: Replacement therapy in thyroid carcinoma patients.
Chart Review Committee: Strong Heart Study.
Contributor: Autologous CD34+ Cell Therapy Trial for Chronic Myocardial Ischemia
(ACT34-CMI).
Principle Investigator: Anemia in Heart Failure study RED-HF Trial
Co-Investigator: Identification of patients with heart failure and PREserved systolic Function:
an Epidemiologic Regional Study (I-PREFER).
87
VASCULAR BIOLOGY RESEARCH:
Principal Investigator: The Role of Angiotensin in the Pathophysiology of Atherosclerosis.
Principal Investigator: ENABLE-2- Endothelin Antagonist Bosentan for Lowering cardiac
Events in heart failure. A Double-Blind, Randomized, Placebo-controlled Study to Assess the
Effects of R0 47- 0203 (bosentan) on the Morbidity and mortality of patients with Chronic
Heart Failure.
Principal Investigator: A Randomized, Double Blind, Placebo Controlled Trial of The
Effects of Orlistat on Endothelium-Dependent Vasodilation in Obese Adults with
Hypercholesterolemia: A Single Center pilot Study.
Principal Investigator: Effects of Endothelin receptor Blockade in Patients with Essential
Hypertension and Congestive Heart Failure.
Principal Investigator: The Effect of Cyclooxygenase Inhibition on The Endothelial Function
Hypercholesterolemic Patients.
Principal Investigator: A Randomized, Double Blind, Placebo Controlled Trial of The
Effects of Orlistat on Endothelium-Dependent Vasodilation in Obese Adults With
Hypercholesterolemia: A Pilot Single Center Study.
Principle Investigator: Study of PDE5 inhibition on myocardial ischemia and vascular
function.
Principle Investigator: Blood pressure response to exercise and endothelial function.
Principle Investigator: A 12 week Randomized Double-blind Placebo-controlled Multicenter
trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg) and Atorvastatin (10mg) in
the Treatment f Subjects with hypercholesterolemia.
Principle Investigator: Women’s Angiographic Vitamin and Estrogen(WAVE) Trial:
Vascular Biology Sub-study.
Principle Investigator: A 24-Week Randomized Multicenter Trial to Evaluate the Efficacy
and Safety ZD4522 and Niaspan Monotherapy, as Well as Selected Combinations of
ZD4522 and Niaspan, in the Treatement of Subjects With Type IIb orIV Hyperlipidemia.
Co-Investigator: A Randomized, Double - Blind, Placebo Controlled Trial of The Effects of
Idoxifene on Endothelium-Dependent Vasodilation in Postmenopausal women with
hypercholesterolemia.
Co-Investigator: Effect of a Soy on Brachial Reactivity in Postmenopausal Women.
Co-Investigator: Phase1 Study of the Effects of Ascending Doses of Adenovirus Mediated
Human FGF- 4 Gene Transfer in Patients with Stable Exertional Angina.
Co-Principal Investigator: Ultrasound Evaluation of Post-Implantation Endothelial Cell
Function in Saphenous Vein Grafts Following Lower Extremity Bypass.
88
VASCULAR BIOLOGY RESEARCH:
Principal Investigator: A Double-Blind, Randomized Comparison Study of the Safety and
Efficacy of Pioglitazone HCL or Glyburide in subjects with Type 2 Diabetes Mellitus post
Acute Myocardial Infarction and/or Percutaneous coronary Intervention.
Principal Investigator: Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril
(OCTAVE).
Principal Investigator: Clinical Protocol for a Double-Blind, Randomized, Placebo Contolled
Trial Evaluating the Safety and Efficacy of Eplerenone in Patients with Heart Failure
Following Acute Myocardial Infarction.
Principal Investigator: A 6-week, Open-Label, Dose-comparison Study to Evaluate the Safety
and Efficacy of Rosuvastatin Versus Atrovastatin, Cervistatin, pravastatin, and Simvastatin in
Subjects With Hypercholesterolemia.
89